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ABSTRACT
Objective: Irritable Bowel Syndrome (IBS) is the most commonly diagnosed
Gastrointestinal (GI) condition in the United States affecting 30 million (10%) people.
Symptoms include abdominal pain, bloating, distension, excessive wind and altered
bowel habits when anatomical abnormalities and inflammation have been excluded. A
low-FODMAP diet is now considered as an effective strategy for managing symptoms of
IBS in Australia, with interest expanding across the world. Several limitations of a lowFODMAP diet pertaining to dietary quality and health benefits have been suggested.
Malabsorbed FODMAPs provide multiple benefits which include a natural laxative effect
due to their osmotic effects, a prebiotic effect with beneficial fermentation by-products
and production of a low glycemic response compared to other carbohydrates.
Additionally, Dietary adherence is crucial to the success of a low-FODMAP diet,
however most people do not find the diet easy to incorporate into their life. Not one study
has looked exclusively at healthy adults or looked at changes in FODMAP intake and diet
quality as compared to established guidelines. A study is needed looking at dietary
quality of low- vs. high-FODMAP diets and should consider how adherence and other
factors that may influence efficacy of the diet.
Design: This study used a single-blinded crossover design. Subjects (n=16) were
instructed about following a low-FODMAP and a high-FODMAP diet for three days
each, presented in a random order and separated by an 11-day wash out period. The study
was entitled “The Carb Study” and diets labeled “diet 1” and “diet 2” without reference
to FODMAP. No food was provided. Dietary instruction was provided for each diet along

with a dietary booklet. Dietary assessment consisted of four 24-hour recalls using NDSR. Recalls assessed the day prior to each intervention period (2 baselines) and assessed
day 3 of each intervention period (2 interventions). FODMAP intake was estimated based
on the sum of fructose, lactose and polyol intake and dietary quality was calculated based
on the Healthy Eating Index 2010 (HEI-2010).
Setting: Free living subjects recruited from a northeastern university.
Subjects: Participants were healthy adults without gastrointestinal disorders (n=16, 63%
female, 20.47±1.77 years).
Results: There was no effect of diet order. There was a non-significant trend for a
between treatment difference in FODMAP intake (F(1,14df)=4.27, p=.058) and a significant
difference between groups in HEI-2010 total score (F(1,14df)=10.45, p=.001). Within the
low-FODMAP treatment, FODMAP intake decreased from 36.30±22.62 grams to
19.29±15.79 grams (-t=2.84, p=.01) and HEI-2010 scores increased from 53.60±17.16 to
63.09±17.23 (t=2.20, p=.04); Energy intake also significantly decreased from 2259±1325
kcals to 1510±795 kcals (-t=2.68, p=.017). Within the high-FODMAP treatment, there
was no change in FODMAP intake (t=.35, p=.731) but HEI-2010 scores decreased from
60.83±12.76 to 52.04±11.27 (-t=2.45, p=.027); There was no difference in energy intake
(1993±962 to 2251± 864, -t=1.57, p=.14)
Conclusions: This study suggests that reducing FODMAP is feasible in healthy, freeliving young adults and that this reduction is associated with an increase in dietary
quality. However, the high-FODMAP intervention in this study was not effective in
increasing FODMAP intake. Future research with larger samples is needed to develop
interventions for increasing healthy FODMAP intake in young adults. In addition, future

research is needed to assess long-term effects of these dietary modifications in healthy
individuals.
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Effect of High- and Low-FODMAP Diet Instruction on FODMAP Intake and
Dietary Quality in Healthy Young Adults

James M. O’Toole, Geoffrey W. Greene, Colleen A. Redding and Kathleen J. Melanson
Department of Nutrition and Food Sciences, University of Rhode Island
Kingston, Rhode Island 02881

ABSTRACT
Objective: The purpose of this study was to investigate the effects of dietary instruction
for low- and high-FODMAP diets on FODMAP intake and dietary quality in healthy
young adults.
Design: This study had a single-blinded crossover design. Subjects (n=16) were
instructed about following a low-FODMAP and a high-FODMAP diet for three days
each, presented in a random order and separated by an 11-day wash out period. The study
was entitled “The Carb Study” and diets were labeled “diet 1” and “diet 2” without
reference to FODMAP. No food was provided. Dietary instruction was provided for each
diet along with a dietary booklet. Dietary assessment consisted of four 24-hour recalls
reflecting the day prior to each intervention period (2 baselines) and assessed day 3 of
each intervention period (2 interventions). FODMAP intake was estimated based on the
sum of fructose, lactose and polyol intake and dietary quality was calculated based on the
Healthy Eating Index-2010 (HEI-2010).
Setting: Free living subjects were recruited from a northeastern university.
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Subjects: Participants were healthy young adults without gastrointestinal disorders
(n=16, 63% female, 20.47±1.77 years).
Results: There was no effect of diet order. There was a non-significant trend for a
between treatment difference in FODMAP intake (F(1,15df)=4.27, p=.06), but a significant
difference between treatment groups in HEI-2010 total score (F(1,14df)=10.45, p=.001).
Within the low-FODMAP treatment, FODMAP intake decreased from 36.30±22.62
grams to 19.29±15.79 grams (-t=2.84, p=.01) and HEI-2010 scores increased from
53.60±17.16 to 63.09±17.23 (t=2.20, p=.04); Energy intake also significantly decreased
from 2259±1325 kcals to 1510±795 kcals (-t=2.68, p=.017). Within the high-FODMAP
treatment, there was no change in FODMAP intake (t=.35, p=.73) but HEI-2010 scores
decreased from 60.83±12.76 to 52.04±11.27 (-t=2.45, p=.027); There was no difference
in energy intake (1993±962 to 2251± 864, -t=1.57, p=.14)
Conclusions: This study suggests that reducing FODMAP is feasible in healthy, freeliving young adults and that this reduction is associated with an increase in dietary
quality. Long term studies are needed to confirm these results. The high-FODMAP
intervention used in this study was not effective in increasing FODMAP intake. Future
research with larger, more diverse samples is needed to develop interventions for
increasing healthful FODMAP intake in young adults. In addition, future research is
needed to assess long-term effects of these dietary modifications in healthy individuals.
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1. INTRODUCTION
In 2005 at Monach University in Australia, the term FODMAP (fermentable
oligo-, di-, mono-saccharides and polyols) was coined to identify a group of poorly
absorbed short-chain carbohydrates (CHO) that when ingested in excess, or when
consumed by individuals with bowel disorders, can induce the gastrointestinal (GI)
symptoms of abdominal pain, bloating, distension, flatulence and diarrhea 12. These CHO
are widespread in the diet 1 and include the oligosaccharides fructooliogosaccharides
(fructans or FOS) and galactooligosaccharides (GOS), the disaccharide lactose, the
monosaccharide fructose and all sugar alcohols (polyols) 2. FODMAPs have three
common functional properties. They are 1) poorly absorbed in the proximal small
intestine, allowing substrate to reach the distal small intestine and proximal colon 2)
small and osmotically-active, increasing the liquidity of luminal content due to osmosis
and 3) rapidly fermented by gut microbiota, increasing the amount of gas in the colon 1.
These characteristics combine to increase luminal distension, the physiological basis for
the genesis of many GI symptoms 1.
It is hypothesized that GI symptoms are created primarily by luminal distention3
creased by fermentation and osmosis 4. Studies have concluded that high-FODMAP diets
induce GI symptoms 5,6, and low-FODMAP diets relieve GI symptoms associated with
functional GI disorders 7-10 with GI symptoms returning when FODMAPs are
reintroduced into the diet 11. Overall GI symptoms have been seen in up to 86% of
Irritable Bowel Syndrome (IBS) patients 7. Accordingly, a low-FODMAP diet has been
recommended for managing GI symptoms for IBS patients12. Applications are expanding
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to enteral feeding formulas 13, a low-FODMAP diet for patients with non-celiac gluten
sensitivity14 and the treatment of infantile colic 15.
A first consideration for FODMAP diets is the overall quality and adequacy of
the diet, as well as associated health benefits. FODMAPs are CHO or related polyols
found in fruits, vegetables, legumes, wheat and other grain products as well as milk and
dairy products. A FODMAP restricted diet limits the available options in these nutrientdense food groups. Additionally, in all populations FODMAPs are malabsorbed 16-20.
Malabsorbed CHO can provide a prebiotic effect due to fermentation by-products 12 and
CHO products high in FODMAPs tend to generate a lower glycemic response compared
to CHO products lower in FODMAPs 21. A low-FODMAP diet may adversely affect gut
microflora and compromise fiber intake 12 and dietitians instructing patients on lowFODMAP diet should provide options for high-fiber alternative fruits, vegetables and
grains as well as adequate sources of calcium and vitamin D 4,16,22. There is limited
evidence comparing the effect of low- vs. high-FODMAP diets on fiber or any other
nutrient intake 12. One retrospective study found limited differences in macronutrient
intake comparing current diets of free-living subjects who had received low-FODMAP
dietary advice two years previously to healthy controls 23.
Another consideration for FODMAP diets is dietary adherence. Adherence
appears to be crucial to the success of a low-FODMAP diet with correlations between
adherence and symptom improvement reported 8. Most people do not find the diet easy
to incorporate into their life 8,10, although controlled studies with IBS patients have shown
high adherence rates both when all foods are provided 11 and when provided with dietary
advice 8. Potential barriers to adherence include buying the appropriate food10,
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implementing the diet8,10, following the diet8 and taste 8,10. There is limited research
available about following a high-FODMAP diet, but individuals are likely to face barriers
given the presence of adverse GI symptoms5,6.
The primary aim of this study was to investigate the effect of dietary instruction
on implementing low- and high-FODMAP diets on FODMAP intake as well as on
dietary quality in healthy, free living, young adults. Secondary aims were to investigate
changes in mood, GI symptoms and subjects’ opinions regarding the diet, as potential
variables that may impact dietary adherence.

2. METHODS
2.1 Subjects
Twenty healthy, young adults, free from GI disorders were enrolled in this
study. Four subjects withdrew from this study, one for medical conditions unrelated to
the study and three failed to compete any assessments beyond baseline. Thus 16 subjects
completed the study and were considered the study sample. Exclusionary GI disorders
included celiac disease, IBS, lactose or gluten intolerance, diverticular disease, colitis
such as Crohn’s disease or ulcerative colitis and stomach ulcers. Additional exclusion
criteria included currently following a weight loss diet, food allergies, smoking,
pregnancy or lactation, diabetes, adrenal disease, kidney or bladder problems, a thyroid
disease or currently taking any appetite suppressant medication. All subjects were
recruited via classroom announcements at the University of Rhode Island or emails sent
to adults who were candidates/participants in previous, nutrition-related studies. Subjects
received a $80 stipend for completing the study. The study was approved by the
6

Institutional Review Board of the University of Rhode Island and subjects provided
written informed consent prior to participating.
2.2 Study Design
The study was a randomized, single-blinded, cross-over study that compared two
diet-interventions in a free-living setting; instruction on low- vs. high-FODMAP diet. In
order to ensure that the diets were single-blinded, the study was entitled “The Carb
Study” and the two interventions were labeled “Diet 1” and “Diet 2” representing the
low-FODMAP diet and high-FODMAP diet respectively. No food was provided. Each
intervention had a corresponding diet instruction booklet that was developed specifically
for this project with foods identified as either high- or low in FODMAPs at the time of
the study1,5,7,23-25. Subjects were provided with 15-minute instructions about each dietary
treatment and asked to follow this booklet to the best of their ability for each three day
intervention period.
An initial screening was conducted to verify potential participants met inclusion
criteria. Body fat percentage was assessed using the BOD POD Body Composition
System (Life Measurement Instruments, Concord, Calif., USA). Subjects where then
randomized to start with either the low-FODMAP diet (order 1) or the high-FODMAP
diet (order 2). Each dietary period was followed by an eleven day wash out period where
subjects consumed their normal diet. Following the wash out period, subjects completed
the remaining dietary intervention. Each intervention lasted three days: Tuesday,
Wednesday, and Thursday.
Four 24 hour recalls were conducted with each subject. At the start of each dietary
intervention period on Tuesday, each 24-hour recall measured dietary intake on Monday
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(baseline). After completion of each intervention period on Friday, each recall measured
intake on Thursday (intervention). FODMAP intake, Healthy Eating Index-2010 (HEI2010) scores, and intake of other selected nutrients were obtained from these 24 hour
recalls. Subjects also completed questionnaires on Fridays of each intervention period
assessing mood and GI symptoms. An additional “opinion regarding the diet”
questionnaire was filled out by a convenience sample of subjects at the end of each
intervention period.
2.3 Dietary Instructions and Diet Booklet
At the baseline visit for each diet, subjects met with a trained research assistant
who provided each subject with a 16 page diet instruction booklet. The booklets
contained a detailed list of recommended and restricted foods corresponding to either the
low-FODMAP diet or the high-FODMAP diet. A brief, 15 minute diet instruction session
was provided, which included identifying encouraged and discouraged foods, tips, and
emphasized the importance of adhering to the diet for research purposes.
2.4 NDSR 24 Hour Food Recall
As described above, four in-person 24 hour recalls were conducted by trained
research assistants. Recalls were conducted using the Nutrition Data System for Research
(NDS-R) software version 12 developed by the Nutrition Coordinating Center (NCC),
University of Minnesota, Minneapolis. NDS-R utilizes a multiple pass method described
in full elsewhere 26. Briefly, pass one included obtaining a quick list of foods consumed
in the past 24 hours. In pass two, participants were asked to produce details regarding
foods on their quick list including portion sizes and amounts eaten. In pass three the list
was recited and participants are asked if any information was forgotten. Food amount
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booklets distributed by the NCC as well as food models were available during food
recalls in order to assure accurate portion sizes.
Foods that were not in the NDS-R database were listed as “missing foods” and
resolved after the interview was completed. Resolution of a missing food required finding
an NDS-R substitute (similar food or a generic version of a food) in the database and
matching that substitute for CHO, protein, fat and kcal. Matching was defined as within
1-3 grams for each macronutrient and within 10 kcals for energy. For some foods, the
potential FODMAP content was considered too variable for application of the normal
missing food substitution protocol (for example ice cream brands and artificially
sweetened beverages). These foods were sent to the NCC, who provided an accurate
nutrient breakdown for those items.
2.5 FODMAP intake
NDS-R output files were used to sum total intake (g) of fructose, lactose and the
polyols (erythritol, inositol, isomalt, lactitol, maltitol, mannitol, pinitol, sorbitol and
xylitol). These items were used to estimate FODMAP intake. Because NCC does not
calculate consumption of galacto-oligosaccharides or fructo-oligosaccharides (GOS or
FOS), estimated FODMAP intake underestimates total FODMAP intake and FODMAP
in this study was defined based on the available FODMAP items. Although
oligosaccharide intake is difficult to estimate, intake of FOS may vary from 3-13 g/day in
western countries 27.
2.6 Dietary Quality: Healthy Eating Index 2010
From NDS-R output files, The Healthy Eating Index 2010 (HEI-2010) 28 was
calculated. The Healthy Eating Index is a measure of dietary quality assessing how well
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an individual’s diet compares with Dietary Guidelines for Americans 2010 (DGA) 29. The
total HEI score ranges from 0 (low) to 100 (high). The total score is based on eight
“adequacy” components: total fruit, whole fruit, total vegetables, greens and beans, whole
grains, dairy, total protein foods, seafood and plant proteins as well as four “moderation”
components: fatty acids, refined grains, sodium, and empty calories 29. Intake is in energy
adjusted per 1,000 kcal.
Calculation of the HEI-2010 for this study was based on a protocol developed by
the NCC based on methods described in a previous study 30. The calculations were made
using Microsoft Excel, 2007 and performed twice to check accuracy.
2.7 Assessment of mood state and gastrointestinal symptoms
All subjects completed two questionnaires regarding their mood state and GI
symptoms prior to bed on the final day of each intervention. The mood questionnaire
used 10-cm VAS response scale anchored at each end “0=Very Little” and “10=Very
Much” that had been used in a previous study 31.The 10 items included: how alert do you
feel, how sad do you feel, how tense do you feel, how much of an effort is it to do
anything, how happy do you feel, how weary do you feel, how calm do you feel, and how
sleepy do you feel. The symptoms questionnaire was a 3-item scale with a similar VAS
response scale based on scales used with IBS patients. Items included: how severe is your
abdominal pain, how severe is your abdominal distention/tightness, and how satisfied are
you with your bowel movements.
2.8 Opinion regarding the diet
Following each intervention 24 hour recall, a convenience sample completed a 4item evaluation of the diet using with a 10-cm VAS response scale from previous
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FODMAP-related studies 8,10,11. Items included: how easy/difficult had it been to
implement the diet, how easy/difficult had it been to adhere to the diet, how easy/difficult
was it to obtain the appropriate food, how would you rank the overall taste.
2.9 Statistics
Statistical analyses were performed using SPSS, version 22.0 (IBM Corporation,
Summers, NY, USA). All variables met criteria for normality. Baseline comparisons
between subjects assigned to the two orders were conducted using t-tests and χ2 tests.
Primary outcomes (grams of FODMAP and HEI-2010 scores) were assessed using
separate 2 (treatment) x 2 (time) x 2 (order) mixed factorial ANOVA followed by withintreatment paired t-tests (baseline and intervention). The η2 was calculated to estimate
effect size using Cohen’s categories of small (.10), medium (.25) and large (.40) 32.
Energy intake (kcal/day) was assessed using similar analyses. All other inferential
analyses of dietary components were performed using a 2 x2 repeated measures ANOVA
where the independent variables were treatment (low- vs. high-FODMAP) and time
(baseline vs. intervention). Paired t-tests compared mood, symptoms and compliance
factors between treatments and Pearsons bivariate correlations explored relationships
between variables. Median scores were reported for diet opinion. P < .05 was considered
statistically significant.

3. RESULTS
There were no differences in demographic variables between subjects assigned to
the two orders. Mean age of the 16 subjects was 20.6 years (range 18-23) and 10 were
female. Further information is presented in Table 1.
11

Values for FODMAP intake and all dietary data including both the total and
subscales of the HEI-2010 did not differ at baseline between the two orders.
There were non-significant trends for grams of FODMAP per day for time
(F(1,14df)=4.38, p=.06, η2=.24) and time*treatment(F(1,14df)= 4.27, p=.06 η2=.23), but no
main effect of order (F(1,14df)=.17, p=.68, = η2.01) or time*treatment*order interaction
(F(1,14df)=.33, p=.57, = η2.02). Within treatments, FODMAP intake decreased in the lowFODMAP treatment (36.30±22.62 grams to 19.29±15.79 grams, t=2.84, p=.01) but there
was no change in the high-FODMAP treatment (35.93±18.08 grams to 34.04±13.72
grams, t=.35, p=.73) (Figure 1).
HEI-2010 scores are listed in Table 2. For total HEI-2010, there was no main
effect of order (F(1,14df)=.16, p=.70, = η2.01), and no treatment*time*order interaction
F(1,14df)=.32, p=.58, η2=.02. There was no main effect for time (F(1,14df)=.02, p=.90,
η2=.00), there was a treatment*time interaction (F(1,14df)=10.45, p=.006, η2=.43) with a
large effect size32. Within treatments, total HEI-2010 scores increased during the lowFODMAP treatment and decreased during the high-FODMAP treatment. When
comparing values during the treatment periods, there was a higher total HEI-2010 score
in the low-FODMAP treatment compared to the high-FODMAP treatment (63.09±17.23
vs. 52.04±11.27; t=2.40, p=.03).
HEI-2010 component scores are presented in Table 2. No time*treatment
interactions were found for any component scores. There was a main effect of time for
the total protein score, (F(1,15df)=4.66, p=.048, η2=.24) and sodium score (F(1,15df)= 4.92,
p=.042, η2=.25).Within treatments, there was an increase in protein score during the lowFODMAP treatment but no change in the high-FODMAP treatment and a decrease in
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sodium score indicating an increase in sodium intake in the high-FODMAP treatment
with no change in the low-FODMAP treatment. Because HEI-2010 component scores
are energy adjusted and there was a change in energy intake (see next paragraph), nonenergy adjusted component scores were calculated. There were time*treatment
interactions for total refined grains (F(1, 15df)= 10.56, p=.005, η2=.41) and total empty
calories (F(1,15df)= 8.02, p=.013, = η2=.35 ).Within treatment analyses found a decrease in
refined grains during the low-FODMAP treatment (6.47±4.65 oz to 2.79±3.46 oz, t=3.63,
p=.002) and no change during the high-FODMAP treatment (5.59±4.62 to 7.20± t=4.63,
p=.13) and a decrease in empty calories in the low-FODMAP treatment (620.02±455.62
kcal to 342.08±283.96 kcal, t=2.64, p=.02) with no change in the high-FODMAP
treatment (552.56±445.97 to 610.49±411.47, t=-.77, p=.46)
Macro- and micronutrient information is presented in Table 3. The primary
analysis was a time*treatment*order ANOVA for energy intake. There was no main
effect of order (F(1,14df)=0.66, p=.43, η2=.05), and no treatment*time*order interaction
(F(1,14df)=0.03, p=.87, η2=.00). There was no main effect of time (F(1,14df)=2.24, p=.16,
η2=.14). There was a significant treatment*time interaction for energy intake
(F(1,14df)=8.62, p=.01, η2=.40) with a large effect size. Within treatments, energy intake
decreased in the low-FODMAP condition but did not change in the high-FODMAP
condition. Looking at specific macronutrients, the most variability came in the
carbohydrate variables. There was a significant treatment*time interaction for total
carbohydrate intake in grams, (F(1,14df)=6.28, p=.02), lactose intake in grams,
(F(1,15df)=5.20, p=.04), calcium intake in mg, (F(1,15df)=4.65, p=.048) and sodium intake in
mg, (F(1,15)=9.98, p=.006). Within treatments there was a decrease in total carbohydrates
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in the low-FODMAP treatment but no change in the high-FODMAP treatment. Lactose
intake decreased during the low-FODMAP treatment and did not change in the highFODMAP treatment. Sodium intake did not change in the low-FODMAP treatment and
increased in the high-FODMAP treatment. Calcium intake did not change in either
treatment, but there was a significant time*treatment interaction, F(1, 15df)= 4.64, p=.048,
η2=.24.
There were no differences in mood score between conditions except “how weary
do you feel” was significantly higher in the low-FODMAP treatment than the highFODMAP treatment (5.86 vs. 3.88, t=2.89, p=.01).There were no differences in
symptoms, however, both abdominal pain and distention had extremely low mean scores
(less than 1) for both treatments and satisfaction with bowel movements did not differ
between treatments (6.29±1.56 vs. 6.36±2.44, t=.13, p=.90).
At the end of each intervention period, a convenience sample of subjects (lowFODMAP n=9, high-FODMAP n=7) were asked about their diets. For the low-FODMAP
diet, more subjects found it difficult to implement the diet (6.4±2.1 vs. 4.8±2.8) and
adhere to the diet (5.7±1.9 vs. 4.6±2.4) and ranked the taste poorly (4.6±2.4 vs. 7.0±1.5)
compared to the high-FODMAP diet.

4. DISCUSSION
4.1 Summary
The purpose of this study was to investigate the effects of dietary instruction for
low- and high-FODMAP diets on dietary quality and FODMAP intake in healthy young
adults. We found that the low-FODMAP diet resulted in an increase in dietary quality
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with a reduction in FODMAP intake. The high-FODMAP diet had no effect on
FODMAP intake while dietary quality decreased. This was the first FODMAP study to
the researchers’ knowledge that looked at changes in dietary quality when implementing
FODMAP diets and indicated that a low-FODMAP diet may have a positive impact on
diet quality. Future studies should also consider this diet’s effect on weight change given
the substantial energy decrease observed here.
Another strength of this study was the use of the HEI-2010. The HEI-2010 is a
valid and reliable measure of dietary quality 33 in conformance with the 2010 Dietary
Guidelines for Americans (DGA) 28. (The HEI utilizes set energy density standard (per
1000 kcals) 28, important since a large difference in energy intake was found). The mean
HEI-2010 scores in this study were higher than for the average U.S. adult, 20-30 years of
age (45.4±1.1) 33 but similar to past studies at the University of Rhode Island 34.
The high-FODMAP intervention did not affect FODMAP intake. During the
high-FODMAP intervention, no food was completely prohibited like foods were during
the low-FODMAP intervention. Instead, low-FODMAP foods were “discouraged” and
high-FODMAP foods were “encouraged”. Future studies should test other types of highFODMAP dietary instructions. A more effective possible future strategy could be to
prescribe a set number of servings of foods on the high-FODMAP diet per meal. Future
research is needed to develop interventions for increasing healthful FODMAP intake in
young adults.
4.2 Subjects
Healthy young adults free of any GI disorders were included in this study. To
the researchers’ knowledge, this is the only FODMAP study that has looked exclusively
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at healthy adults. Previous FODMAP focused on populations with IBS 5-10. In one of the
few FODMAP studies that included healthy adults, Ong et al.5 compared healthy adults
(n=15) to IBS patients (n=15) and compared high-FODMAP conditions (50g/day) to lowFODMAP conditions (9 g/day) during a two day intervention. The study was a singleblinded crossover intervention comparing low- vs. high-FODMAP conditions in which
all foods were provided for two days. The study found that a high-FODMAP diet had no
effect on symptoms except for increased flatulence in healthy adults. Similarly, our study
found that both abdominal pain and distention were not factors in this population
however we did not assess flatulence.
4.3 The effect of a low-FOMAP diet on Dietary Quality
Due to the restriction of fruits, vegetables, dairy and legumes, dietary quality
was hypothesized to decrease on the low-FODMAP diet, whereas the opposite occurred.
Looking at the change in dietary quality, the low-FODMAP intervention was most
effective at restricting refined products and “empty calories” including solid fat, added
sugar and sodium-rich foods. This restriction contributed to the large decrease in energy
and carbohydrate intake. These results indicate that a low-FODMAP diet has potential to
have a positive influence on dietary quality in college students but future studies are
needed with adults showing more dietary diversity. The implications of the decrease in
energy intake should be examined in future research.
To the researchers’ knowledge this was the first FODMAP study that examined
dietary quality in healthy adults. Ostgaard et al. 23 examined diet composition of IBS
patients who received low-FODMAP education (guided n=43) two years prior. This
study showed no difference between the guided and control group for calories, CHO,
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protein, fat, sugars or fiber intake and did not measure dietary quality. This study used
food frequency questionnaires (FFQ) to measure nutrient intakes as opposed to our study
which used 24 hour food recalls.
4.4 The effect of a low-FODMAP diet on other health benefits
Fibers provide plant structure and are thus found in plant-derived vegetables,
fruits, whole grains and legumes 35. A low-FODMAP diet restricts these food groups,
suggesting fiber intake might be of concern. In our study however fiber intake did not
change in either intervention. Total, soluble and insoluble fiber intake were considerably
lower than the recommendations36, indicating attention should be paid to ensuring
assuring adequate fiber in FODMAP modified diets in this population 12.
FODMAPs are low glycemic index nutrients 37,38 producing a lower glycemic
response compared to other CHO 21. Low glycemic index foods may provide benefits in
the treatment and prevention of metabolic syndrome, diabetes and CVD 39-42, due to their
ability to maintain better regulation on blood glucose, decreases oxidative stress and
lowering inflammation 42. No other study has considered how implementing a lowFODMAP diet effects overall glycemic load or glycemic index. In our study, glycemic
load (glucose reference) significantly decreased on the low-FODMAP diet, however,
glycemic index (glucose reference) did not change (62.33±5.27 to 60.98±7.41, t=.597,
p=.56). This change may very well be due to the decrease in overall CHO intake. Future
studies should consider how FODMAP intake affects blood glucose regulation.
4.5 The effect of overall FODMAP intake for the low-FODMAP diet
The low-FODMAP intervention was successful at reducing overall FODMAP
intake and lactose intake; although it is important to keep in mind that oligosaccharides
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were not calculated (see section 4.5, strengths and limitations). Overall FODMAP intake
was almost cut in half on the low-FODMAP diet and 81% of subjects decreased
FODMAP intake.
The low-FODMAP diet strategy does not recommend a FODMAP elimination
diet for long term use and stresses the importance of reducing any unnecessary
restrictions that may compromise nutritional status 1,12; The use of a strict low-FODMAP
diet is warranted for 6-8 weeks 1 and subsequently discontinued if symptoms are not
controlled 4,43. The cutoff point used to define low-FODMAP is based on the individual’s
tolerance and typical eating pattern 1, therefore to the researcher’s knowledge there is no
formal definition of “low-FODMAP”. A previous study where all foods were provided
defined low-FODMAP intake as <9 g/day5, which is lower than the 19.29 g consumed
during our intervention. However comparisons to a standardized definition for low- or
high-FODMAP cannot be made.
The low-FODMAP diet reduced lactose intake to under 3 grams and there was
a nonsignificant trend towards calcium reduction. The “dairy” HEI-component, and
vitamin D intake did not significantly decrease. The scores also rated poorly compared to
desirable standards. The dairy score was lower than the average score for U.S. adults ages
20-30 (5.6±0.2) despite the total HEI score greatly exceeding the population average
(45.4±1.1) 33. Calcium intake at baseline exceeded the RDA of 1,000 mg/d 44 but
dropped below the EAR of 800 mg/d 45 during the low-FODMAP diet. Vitamin D intake
did not meet the EAR 45 at any point of the study. Calcium and vitamin D status in any
nutrition intervention that greatly restricts lactose and/or dairy products should be
considered 22.
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4.6 Strengths and Limitations
There were several limitations. FOS and GOS were not included because they
are not analyzed by NDS-R. Future studies could use Barrett and Gibson’s food
frequency questionnaire46. A second limitation was that only a single 24 hour food recall
was used per intervention period which provides an unstable estimate of usual intake26,47.
A third limitation was that the high-FODMAP intervention was not effective at reducing
FODMAP intake. Other limitations to this study include a small sample size, a short
duration and reduced generalizability due to the homogeneity of college-aged subjects.
Strengths of the study included the use of the HEI-2010, a well controlled, randomized
single-blinded crossover experimental design, and use of healthy adults.

5. CONCLUSION
Dietary instruction for implementing a low-FODMAP diet may be effective in
helping young healthy individuals reduce FODMAP intake without compromising
overall dietary quality. Although calcium intake was low, this study found that the lowFODMAP diet was associated with a reduction in overall energy and carbohydrate intake
as well as glycemic load. Long term studies are needed to confirm these results. Future
research is also needed to assess the effects of increasing FODMAP intake in young
adults.
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Table 1: Demographics, n=16
Variable
Female, n (%)
Male, n (%)
Age (yr), M±SD
Body Weight (kg), M±SD
Body Mass Index (kg/m2), M±SD
Waist Circumference (cm), M±SD
Body Fat Percent (%)*, M±SD

10 (62.5)
6 (37.5%)
20.47±1.77
63.85±11.65
22.21±2.45
78.98±7.57
18.80±10.37

*body fat percent obtained via BOD POD Body Composition
System (Life Measurement Instruments, Concord, Calif., USA)
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Figure 1: Comparison of
FODMAP intake for lowvs. high-FODMAP diets.
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Table 2: Diet quality as measured by the Healthy Eating Indix-2010
Low-FODMAP diet
HEI Component

Baseline

Day 3

Total Fruit Score

1.93±1.99

Whole Fruit Score

High-FODMAP diet
Baseline

Day 3

2.83±2.19

Δ
0.9

2.35±2.21

2.46±2.41

3.01±2.30

0.55

Total Vegetable Score

3.38±2.02

3.62±1.94

Greens & Beans

0.71±1.91

Whole Grain Score

ANOVAa
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F (1,15)

η2

2.29±1.69

Δ
-0.06

1.19

-

2.52±2.19

2.37±2.04

-0.15

1.23

-

0.24

4.32±1.19

3.22±1.88

-1.1

2.38

-

2.39±2.51

1.68

2.18±2.24

1.89±2.28

-0.29

4.39

-

3.59±3.89

4.28±4.74

0.68

4.36±4.24

4.24±3.96

-0.11

0.28

-

Diary Score

6.73±3.34

4.64±3.73

-2.09

7.17±3.07

6.80±3.63

-0.37

2.64

-

Total Protein Score

2.99±1.75

4.40±1.30

1.41*

3.55±1.89

3.94±1.38

0.38

4.20

-

Seafood & Plant Score

1.53±2.03

2.18±2.56

0.65

2.50±2.58

1.22±2.02

-1.28

1.75

-

Fatty Acid Score

4.39±3.97

6.78±3.79

2.39

4.10±3.86

3.01±2.75

-1.09

3.53

-

Refined Grain Score

5.28±4.28

7.69±3.69

2.4

6.41±4.06

5.03±3.82

-1.38

4.32

-

Sodium Score

5.77±3.72

4.96±4.49

-0.81

6.13±3.50

2.99±3.35

-3.14**

1.78

-

Empty Calorie Score

14.83±5.23

16.31±5.74

1.48

15.25±4.37

15.04±5.37

-0.21

0.97

-

53.60±17.16

63.09±17.23

9.49*

60.83±12.76

52.04±11.27

-8.79*

10.452**

0.43

HEI-2010

b

*= p<.01, **=p<.001
A 2 (Order) X 2 (Treatment) X 2 (time) mixed factorial ANOVA with post hoc ttest was used for total HEI-2010
and a 2 (treatment) X 2 (Time) repeated measured ANOVA with post hoc ttest was used for individual components
a

= Time*treatment interaction F statistic reported

b

= A measure of dietary quality reflecting federal guidelines. Scores range from 0-100 with higher scores
reflecting better diet quality. The value is expressed as a per 1,000 kcal standard.

Table 3: Intake of selected nutrients in Low- vs. High-FODMAP diets
Low-FODMAP diet

ANOVAa

High-FODMAP diet

Pre-Intervention

Day 3

Δ

Pre-Intervention

Day 3

Δ

F(1,14)

η2

2255.83±1325.14

1510.11±794.96

-745.71*

1993.24±962.44

2251.92±864.46

258.68

8.62*

0.38

83.76±65.77
75.69±53.08
291.72±186.21
126.09±86.00

55.24±33.28
74.12±56.78
182.86±116.27
72.22±59.00

-28.52
-1.57
-108.85*
-53.87*

70.11±42.01
74.92±34.14
277.60±144.01
107.51±61.14

78.54±34.77
91.53±36.51
288.01±131.68
130.80±79.10

8.43
16.61
10.41
23.29

3.68
1.30

-

6.28*
5.78*

0.30
0.28

30.76±10.88
13.45±5.15
51.97±13.32

32.92±13.26
19.21±9.02
46.96±16.66

2.16
5.76**
-5.01

29.59±7.23
15.79±5.24
54.28±8.02

30.79±8.56
17.41±6.09
49.47±8.78

1.2
1.62
-4.81

0.06
2.74
0.15

-

Total Fiber (g)
Soluble (g)
Insoluble (g)
Glucose (g)
Fructose (g)

21.22±14.15
6.83±4.66
14.17±9.82
21.87±14.73
20.52±15.03

16.13±8.27
4.47±3.08
11.59±5.75
18.52±16.07
16.10±15.03

-5.09
-2.36
-2.58
-3.36
-4.42

24.37±15.74
7.01±4.29
17.26±12.35
19.22±10.95
19.05±9.64

19.46±9.00
6.42±3.60
12.89±5.90
21.07±13.24
20.96±10.80

-4.91
-0.58
-4.37
1.85
1.90

0.00
0.79
0.17
0.70
0.99

-

Lactose (g)
Sucrose (g)
Total Sugars (g)

14.35±14.08
64.13±73.51
124.14±101.37

2.89±5.79
38.59±32.68
76.99±53.22

-11.46**
-25.54
-47.15

15.96±16.40
69.04±65.49
126.96±83.41

11.29±12.11
60.64±70.53
118.47±80.88

-4.68
-8.40
-8.49

5.21*
0.62

0.26
-

74.49±80.17

44.41±53.58

-30.09

77.07±80.23

75.03±73.62

-2.03

2.22
1.74

-

Item
Calories (kcals)
Total:
Fat (g)
Protein (g)
Carbohydrate (g)
Starch(g)
% Calories from:
Fat
Protein
Carbohydrate
Sugars & Fibers
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Added Sugar (g) by total sugar
Vitamins & Minerals:
Vitamin D (mcg)
Calcium (mg)
Phosphorus (mg)
Sodium (mg)
Potassium (mg)
Glycemic load

5.57±6.93

3.89±5.29

-1.68

4.75±3.54

3.86±2.55

-0.89

0.23

-

1085.97±794.13
1278.96±803.39
3210±1760
2770.93±1429.83
170.46±117.52

689.12±451.61
998.83±578.54
2540±1810
2182.15±1171.89
105.15±77.33

-396.85
-280.13
-670
-588.78
-65.31*

996.46±475.41
1314.86±583.87
2730±1100
2549.06±752.78
151.88±84.39

912.64±316.42
1270.30±413.24
4260±1910
2280.55±758.72
162.29±84.52

-83.83
-44.56
1530**
-268.52
11

4.65*
1.51

0.24
-

9.98**
0.51

0.40
-

6.77*

0.31

*p<.05, **p<=.01
a

= Time x treatment interaction F statistic reported

A 2 (Order) X 2 (Treatment) X 2 (time) mixed ANOVA used for total calories intake and a 2 x 2 repeated measures ANOVA with post hoc ttests were used for all components

APPENDICES

Appendix A: Review of Literature

1.

Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS) is the most commonly diagnosed

Gastrointestinal (GI) condition in the United States 48. In 2012, it was estimated that 10%
of Americans meet the diagnosable criteria for IBS, translating to 30 million people 48. It
is considered a functional disorder with no known identifiable underlying
pathophysiology 49 with diagnosis based on exclusion of other conditions rather than a
biological marker and may involve lengthy, and intrusive procedures such as
sigmoidoscopies and barium enemas 50. Historically, medical management has focused
on individualized symptomatic treatment48. IBS is an umbrella term that incorporates a
spectrum of chronic or recurrent symptoms including abdominal pain, bloating,
distension, excessive wind and altered bowel habits when anatomical abnormalities and
inflammation have been excluded 12. Symptoms are experienced to varying degrees, often
with a single symptom manifesting predominately. Some symptoms can be perceived to a
lesser degree by the healthy population, indicating that some treatment strategies may be
beneficial to the general population5.

1.2 IBS’S Burden on Healthcare and Affect on People’s HRQoL
It is well documented that IBS is associated with a decrease in people’s sense of
well-being, or Health Related Quality of Life (HRQoL) in relation to the general
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population 51-54. In 2009, Spiegel et al. 51 found that patients with IBS visit the doctor
more frequently, use more diagnostic tests, consume more medications, miss more
workdays, have lower work productivity, are hospitalized more frequently, and consume
more overall direct costs than those without IBS. Recent studies have compared HRQoL
of IBS patients to patients with other gastrointestinal conditions. A 2000 study looked at
877 ambulatory adults from 1994-1998 and compared HRQoL of IBS patients with the
general population and with patients with GERD, Diabetes Mellitus (DM), depression
and End Stage Renal Disease (ESRD) on dialysis 55. The study found that patients with
IBS had significantly worse reported HRQoL than the general population and patients
with GERD. Additionally, patients with IBS scored significantly lower on selected
aspects of HRQoL than patients with DM and ESRD. The study concluded that IBS
patients experience significant impairments in HRQoL and these impairments are most
pronounced in energy/fatigue, role limitation caused by physical health problems, bodily
pain and general health perception 53.
IBS’s impact on the healthcare system has also been heavily researched. The
overall associated cost is 1.6 billion in direct and 19.2 billion in indirect annual costs 56.
The mean annual direct health care cost per patient is $5,049 and the annual out-ofpocket expenses (for example non-prescription medication and alternative treatment like
special diets and therapy per patient) is $406 57. The individual cost has been found to
increase based on disease severity and recent exacerbation of bowel symptoms 57.
Regarding burden for healthcare practitioners, IBS accounts for 12% of the patients seen
in the primary care practice and is the largest diagnostic group seen in GI practice 58 with
inpatient care accounting for 17.5% of total costs 57.
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1.3 Treatment of IBS Focusing on the Role of Diet
Current treatments for IBS include pharmaceuticals such as antispasmodics and
stool softeners 12, psychological therapy, fiber, probiotics and lifestyle and diet
modification 8. The American Gastrointestinal Association (AGA) suggests that treatment
of IBS should be based in part on the correlation of IBS symptoms with food intake and
defecation 58. Food’s role in symptom management is further reinforced by an Academy
of Nutrition and Dietetics (AND) study that concluded symptoms in one quarter of IBS
patients may be caused or exacerbated by one or more dietary components 59 as well as
multiple studies finding people with IBS believe food plays a significant role in
exacerbation of their symptoms 60-64.
Multiple foods or food components have been examined regarding their role in
IBS symptom exacerbation. Dietary fat, caffeine and alcohol have been sought after as
potential triggers with physiological mechanisms suggesting that these may play a role,
but inconsistencies in symptom improvement have been seen when these items are
restricted 12. In 2009, the AND 59 released a position paper comparing the current
practical treatment strategies for IBS. The position paper states that the traditional dietary
strategy of increased fiber is only marginally beneficial. In addition, a subgroup of fiber,
insoluble fiber, may actually worsen symptoms, making the traditional dietary advice
confusing and potentially counterproductive. Indeed, randomized controlled clinical trials
have shown conflicting results 65,66. The AND also examined new treatment strategies,
specifically supplemental prebiotics and probiotics and dietary fermentable oligo-, dimonosaccharides and polyols (FODMAPs) restriction. FODMAP is a term used to
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identify a collection of poorly digested, highly osmotic and rapidly fermented short chain
carbohydrates (CHO). At the time of that paper, the AND stated that prebiotics have not
been adequately tested, the usefulness of probiotics was not yet established and the
restriction of dietary FODMAPs may be beneficial in reducing IBS symptoms, but
confirmatory studies were needed59.

2.

FODMAP: Definition & General Properties
In 2005 the term FODMAP was coined to identify a collection of poorly

digested, highly osmotic and rapidly fermented short chain carbohydrates (CHO).
FODMAP stands for fermentable oligosaccharides, disaccharides, monosaccharides and
polyols. They are widespread in the diet 1 and include the oligosaccharides,
fructooliogosaccharides (fructans or FOS), found in wheat, rye, onions and garlic, and
galactooligosaccharides (GOS) found in legumes and some nuts; the disaccharide lactose
found in milk products; the monosaccharide fructose in apples, pears, watermelons,
mango and asparagus and the sugar polyols used as artificial sweeteners and naturally
occurring as sorbitol in stone fruits and mannitol in mushrooms and cauliflower 12. Both
dietary fibers and resistant starches are also poorly digested in the small intestine and
reach the colon, however they are not fermented as fast and are less osmotically active
making them less likely to induce gastrointestinal symptoms 12 and thus not considered as
part of this IBS-focused dietary strategy. Indeed, studies have shown the benefits of lowFODMAP diets in alleviating IBS symptoms even when adequate resistant starches and
fibers are included 5,7.
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FODMAPs have three common functional properties. They are 1) poorly
absorbed in the proximal small intestine, allowing substrate to reach the distal small
intestine and proximal colon 2) small and osmotically-active, which increases the
liquidity of luminal content due to osmosis and 3) rapidly fermented by gut microbiota,
increasing the amount of gas present in the colon. These three characteristics combined to
increase luminal distension 1, the basis for the genesis of many functional gut syndrome1.
A low-FODMAP diet is now considered an effective strategy for managing symptoms of
IBS in Australia, with interest expanding across the world 12. Studies have also shown
that a low-FODMAP diet can relieve gastrointestinal symptoms in up to 70% of patients
with Crohn’s disease and Ulcerative Colitis10, two conditions that historically exhibit
functional gastrointestinal symptoms similar to IBS. Additionally, FODMAPs in enternal
nutrition (EN) feeding formulas have been suggested as a contributing factor to high
frequency of diarrhea in patients receiving EN support 67.The predominant symptoms of
IBS are diarrhea, bloating, abdominal pain and flatus 48. It is important to note that lowFODMAP diets do not treat IBS; rather they provide a therapeutic strategy for managing
symptoms. The osmotic nature of FODMAPs contributes to diarrhea and the fermentation
gaseous by-products contribute to abdominal pain and flatus 12. The improvement to
constipation-predominate IBS seen by the FODMAP approach needs further exploration
12

. Lastly, the threshold of visceral pain, or visceral sensitivity may help determine the

severity of symptoms, in particular abdominal pain 3.

2.2 FODMAP Studies: Studies Confirming the Success of Low-FODMAP in Treating
Gastrointestinal Symptoms
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Since the AND’s 2009 position paper, multiple studies have concluded that
high-FODMAP diets induce gastrointestinal symptoms 5,6 and that a low FODMAP diet
relieves gastrointestinal symptoms associated with functional gastrointestinal disorders 710

. Overall symptom improvement has been seen in up to 86% of IBS patients7 and,

although the majority of FODMAP studies focus in on IBS patients, limited studies on
patients with Inflammatory Bowel Disease (IBD) displaying IBS-like symptoms show up
to 70% symptom improvement 8. The first and only prospective study confirming that
low-FODMAP diet improve IBS symptoms was conducted in 2013 8. The study
examined 90 patients with a mean follow up of 15.7 months. With the exception of
‘burping’ (p=.275), ‘feeling full even long after stopping eating’ (p=.051) and ‘the
passage of mucus’(p=.890), (all of which are symptoms not traditionally associated with
IBS), there was a significant improvement in all of the 20 questions pertaining to bowel
habits. This included significant improvements in abdominal pain, bloating, flatulence
and diarrhea (p<.0001 for all) 8, the predominant symptoms of IBS 48.
Shepherd et al. 11 conducted the first and only randomized placebo-controlled
study showing evidence that restriction of FODMAPs causes symptomatic improvement
in IBS patients. The study was a 25 subject, double-blinded, randomized, quadruple arm
placebo-controlled rechallenge trial. The aim of the study was to determine if
improvement in symptoms in IBS patient following fructose restriction was due to
fructose specifically or FODMAPs in general. The 25 patients were provided all foods for
the study duration. The subjects first completed an initial 4 week period where foods that
contained FODMAP were restricted, followed by a 26 day period where subjects
consumed specially formulated test drinks containing fructose, fructans, a combination of
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fructose and fructans or glucose (the control) in different dosages. Symptoms were
measured using daily diaries and questionnaires. For each arm, participants started with
the low dose (50mL/week) for the first 3 days, followed by the medium dose (100
mL/day) for 3 days and finally the high dose (170 ml/d) for the remaining 2 weeks of
each arm. Dose stages were increased as tolerated with no significant difference in
patients’ ability to reach the high dose in any of the drinks. Each 500 ml bottle contained
19 g fructans, 50 g fructose, a combination of the fructose and fructans representing a
FODMAP containing drink, or 20 g glucose representing the control. The test drinks
were initially tested on seven healthy adults without IBS. None of the healthy adults
reported their symptoms were not adequately controlled; However four healthy subjects
reported mild symptoms, three reported bloating (VAS scores of 27,35,43 mm) and four
reported increased wind (VAS scores 27,28,33, and 44 mm). Following the initial arm,
subjects could not begin the subsequent arm of the study until baseline symptoms were
obtained for at least seven days. The overall adherence was >95%. The median wash out
period was 14 days. The study resulted in 70% of patients receiving fructose, 77%
receiving fructans and 79% receiving a high FODMAP drink reported uncontrolled
symptoms compared to only 14% of subjects receiving glucose (p≤.002). Every IBS
symptom evaluated was significantly greater with ingestion of the high FODMAP drink
than the control. In addition, intensity of overall symptoms increased as the doses of
fructose, fructans and fructose-fructan mix increased (p<.01 for all dose comparison) but
the severity of overall symptoms did not change for increasing doses of glucose (p>.2).

2.3 Comparing low-FOMDAP diets to standard dietary advice
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In 2011 Staudacher et al.7 compared symptom responses in IBS patients after
advice to follow a diet low in FODMAPs verses following the standard dietary advice by
on the UK National Institute for Health and Clinical Excellence (NICE) guidelines. The
study took place in the United Kingdom and all dietary advice was given by experienced
dietitians. The NICE guidelines consist of general dietary advice including regular meal
patterns (adjusting fiber intake and reducing alcohol and caffeine) as well as symptom
specific guidelines 7. The study looked at 82 consecutive IBS patients (standard n=39,
low-FODMAP n=43) who attended a follow-up dietetic outpatient appointment after
following dietary advice for management of IBS for at least 6 months. The validated IBS
Global Improvement Scale was used to compare symptom changes between the two
groups. The study found that the low-FODMAP diet produced greater satisfaction in
symptom responses (76%) compared to the standard advice (54% p<.038) and better
overall symptom responses (86%) compared to the standard group (49% p<.001).
Improved symptoms included reduced bloating, abdominal pain and flatulence.

2.4 FODMAP malabsorption
Although all FODMAPs are poorly absorbed, the anatomical reasoning
underlying the incomplete or complete lack of absorption differs among FODMAPs.
Fructose is a hexose sugar being increasingly consumed in its monosaccharide form as an
added sweetener and in its more natural forms such as fruit juice 68.There is no clearly
established fructose malabsorption mechanism 68 and most of the understanding of
fructose transport has been based on animal studies 69. In the conventional model of
fructose transport, fructose is transported across the apical membrane of intestinal
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epithelial cells by the facilitative transporter GLUT5 68, a facilitative transporter specific
to fructose. Transport of fructose across the basolateral membrane of gastrointestinal
epithelial cells takes place by means of the facilitative transorter GLUT2, which has the
ability to transport both hexose monosacchrides, fructose and glucose 68. A study
conducted in GLUT5 knockout mice identified GLUT5 as the primary protein
responsible for fructose absorption and malabsorption 70. These GLUT5 knockout mice
displayed decreased fructose absorption by 75% and decreased serum fructose by 90%
when compared to wild-type mice. Furthurmore, GLUT5 knockout mice fed a high
fructose diet experienced more distended colons and significantly more fecal contents
including fluid and gas compared to mice on a normal or high glucose diet. Fructose
absorption in humans appears to be limited at high concentrations of fructose consistent
with the absorption capacity of a facilitative transport system, and appears to occur as a
result of a reduced absorption threshold 68. This means that among both healthy and
symptomatic people, there is a range of fructose absorptive capacity that is balanced
against dietary fructose consumption 68.
Lactose malabsorption is a common condition characterized by a deficiency of
lactase, an intestinal cell produced enzyme occurring in the brush border membrane of
the intestinal mucosa that hydrolyzes lactose to its components, galactose and glucose 71.
Secodary hypolactasia can be the result of any condition that damages the small intestinal
mucosa brush border or significantly increases the gastrointestinal transit time 71. Both of
these conditions result in malabsorbed lactose reaching the colon. Only when the
malabsorbed lactose is associated with clinical manifestation of bloating, flatulence,
abdominal pain and diarrhea is it referred to as “lactose intolerance”71.
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FOS or Fructans are oligo- and polysaccharides of fructose with a glucose
terminal end 16,72. They are classified according to their bonds as inulins (β1-2 bonds) or
levans (β2-6 bonds) with most dietary sources coming from inulins 16. When an inulin
has <10 degrees of polymerization (DP) it is referred to as a fructo-oligosaccharide,
whereas >10 DP is referred to as an inulin 16. The β-bonds that hold fructose molecules
together are unable to be hydrolyzed by human digestive enzymes, thus theoretically FOS
travel unabsorbed in all humans, resulting in more than 90% of fructans reaching the
colon 16. That being said, FOS absorption in the human gastrointestinal tracts has not
been assessed, studies come exclusively from rat models 73.
GOS are nondigestible CHO usually composed of 2-10 molecules of galactose
and 1 molecule of glucose 74. The two most common dietary sources are raffinose,
comprised of one fructose, one glucose and one galatose molecule and stachyose, which
is a raffinose with one an additional galactose 16. Humans lack α-galactosidase, the
enzyme that hydrolyses the galactosidic linkages of stachyose and raffinose to their
simple sugar constituents, resulting in minimal absorption in humans 16.
Polyols are sugar alcohols that include sorbitol, lycasin, malitol and mannitol,
75,76

. Sorbitol and mannitol are six-carbon polyols isomers that are only partly absorbed

via passive diffusion across the small intestine epithelium 76, with a total of 80% ingested
reaching the colon 16.

2.5 Intestinal gas production and the hydrogen breath test
Once CHO are malabsorbed in the small intestine they become substrate for
bacteria fermentation, which in turn releases gaseous byproduct into the lumen. More
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than 99% of intestinal gas is hydrogen (H2), oxygen (O2), methane (CH4), carbon dioxide
(CO2) and nitrogen (N2) while less than 1% is composed of various odoriferous gases 77.
CO2, H2 and CH4 represent the predominant, intraluminal gases 77. H2 and CH4 are
generated solely by bacterial metabolic processes, demonstrated by studies conducted
with both germ free rats and newborns, which show that these gases are not produced
during the first 12 hours of life 78,79. Colonic gases will be used by bacteria, excreted in
stool or absorbed into the blood stream 80. Absorbed H2 is almost completely cleared in a
single passage through the lungs 80, thus the measurement of breath H2 concentration may
be considered an expression of intestinal H2 production 81. The human colon contains
around 10^15 bacteria 82, predominantly anaerobes that produce large quantities of
hydrogen gas 83. Anaerobic bacteria prefer to metabolize sugar molecules, which get
broken down into short-chain fatty acids (SCFA), CO2 and H2 83. Like H2, SCFA generate
an osmotic gradient, attracting water into the colon, which can lead to diarrhea 83. There
are two main pathways for colonic H2 disposal, including conversion to methane by
methanogens and hydrogen sulfide production from reduction of sulfate by sulfate
reducing bacteria 77. Of the general population, 30% have microbia containing enough
methanogens to allow for consumption of large quantities of hydrogen, while producing
small amounts of H2 84 made possible since four moles of H2 can be reduced to a single
mole of CH477.
The hydrogen-breath test is a simple, non-invasive tool currently used in
gastroenterology to diagnose certain clinical conditions, thus avoiding more invasive test
85

. Additionally, it represents the most effective test for CHO malabsorption 86 and is used

extensively in both individual and collective FODMAP studies. It relies on the fact that
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humans do not normally produce H2 and thus its presence indicates breakdown of CHO
in the intestines, primarily the colon, by anaerobic bacteria 87. FODMAPs have been
called fast food for bacteria 16 and breath hydrogen testing studies have shown that CHO
molecules with DP<10, such as FODMAPs, are broken down twice as fast those with
DP>10 88. In 2000, a breath hydrogen detection machine entitled the Quintron Microlyzer
Breath H2 Analyzer was validated for diagnosis of CHO malabsorption 87.

2.6 FODMAP malabsorption in healthy adults
The predominant way that diet alters luminal distention is via intraluminal gas
production 5. Even in healthy individuals, FODMAPs are malabsorbed 12, shown using
breath hydrogen testing to compare the prevalence of CHO malabsorption between
functional GI disorder (FGID) patients and healthy subjects. Barrett et al. 17 found that
34% of healthy people (n=71) malabsorb fructose compared with 45% of those with
FGID (n=201) when given 35 g of fructose prior to breath hydrogen testing
(malabsorption was defined as >10 ppm). In that same study 17 it was demonstrated that
lactose malabsorption occurred in 16% of healthy adults compared to 23% with FGID
after ingesting 50 g of lactose. Two years later, Yao et al 18 conducted a randomized,
double-blinded, placebo-controlled cross over study comparing polyol malabsorption
between IBS patients (n=20) and healthy adults (n=21) after ingestion of 10 g of polyols.
The study found that IBS patients had less malabsorption than healthy adults (sorbitol
1629 ± 210 ppm. 4 hour vs. control 2766 ±591; mannitol 601± 228 vs 2062 ± 468, p=
0.02; t-test) and the prevalence of malabsorption among healthy adults was 60%. As far
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as the oligosaccharide FODMAPs, as stated previously, malabsorption occurs in
everyone 19,20.
Intestinal gas produced after ingestion of total FODMAP in both healthy
individuals and individuals with IBS has also been considered. In 2010, Ong et al.5
examined both healthy individuals (n=15) and patients with IBS (n=15) and compared
high-FODMAP diets (50g/day) to low-FODMAP diets (9 g/day) during a two day
intervention. The design was a single-blinded crossover intervention where all food was
provided. Breath hydrogen samples were collected hourly over 14h on day two of each
diet. The study found higher levels of breath hydrogen produced over the day with the
high-FODMAP diet for healthy subjects (181± 77 ppm vs. 62±23 ppm; mean p<.0001)
and patients with IBS (242±79 vs. 62±23; p<.0001) 5.

2.7 Importance of visceral sensitivity in symptom production
With CHO malabsorption present in both healthy population and FGID patients,
and fermentation patterns similar in both populations, a low threshold for visceral pain
appears to be the key mediator for gastrointestional symptoms manifestation, particularly
abdominal pain3. This was demonstrated by Richie et al. 3 who studied the effect of
inflating a balloon into the distal colon and compared pain responses between IBS
patients (n=67) and healthy adults (n=16). The study found that inflation to 60 mL caused
pain in 6% of the control at a mean diameter of 3.8 cm and in 55% of patients with IBS at
a mean diameter of 3.4, despite that gut wall tension at that volume appeared to be
normal in both groups and gut wall diameter could be further increased. Additionally, in
6% of the controls and 52% of patients with IBS, pain occurred at balloon diameters that
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could still be increased by 10% or more with further inflation, pointing to a low threshold
for visceral pain in patients with IBS compared to healthy adults 3.

2.8 Poorly digestible and Osmotic effect of FODMAP
The proposition that dietary FODMAPs increase the liquidity of luminal content
due to osmotic properties was explored in a ‘proof-of-concept study’ in 2007 9 and
further explored in a similar study in 20106. The Australian study examined the change in
frequency and consistency of effluent of patients without a colon when reducing
consumption of dietary FODMAPs. The use of colonoscopy patients controlled for the
reabsorptive capacities of the large bowel to help better understand how much liquid
diffuses into the intraluminal space in the small intestine. In the small, 15 subject study
that incorporated both retrospective and prospective data, patients who recently received
a colectomy and ileal pouch formation (n=13) or a ileorectal anastomosis (n=2) had the
frequency and consistency of effluent output per day measured prior to and during a lowFODMAP intervention. All participants had breath hydrogen testing done prior to
participating in the study. Regarding breath hydrogen testing, 50% of the participants did
not produce hydrogen. This is understandable given the absence of colonic fermentation
in patients without a colon. In the retrospective arm of the study, five of the seven
patients had significant improvement in stool frequency (8-4 stools; p=0.02) and
consistency as shown by patient self reporting 9. In addition, patients uniformly reported
that reintroduction of prohibited foods worsened symptoms 9. In the prospective arm of
the study, (n=5), no significant change in stool frequency (median 6 to 5 per day; p=ns)
occurred. The lack of significance was attributed to acute or chronic pouchitis
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experienced by three subjects 9. However the reasoning for the lack of response in
patients with inflammation was unclear 9.
Similarly, a 2010, randomized, single-blinded cross over study where subjects
without a colon were given high-FODMAP diets found that effluent liquid output closely
related to FODMAP output, clearly demonstrating FODMAPs osmotic properties 6. This
was found by measuring FODMAP output in the stool of subjects. The study consisted of
twelve illeostomy patients who for four days consumed diets differing only in FODMAP
content. Effluent was collected for 14 hours during the final day of each intervention.
Effluent recovered from the high-FODMAP diet contained 32% (range 6-73) of ingested
sorbitol and fructans 6. Furthermore, stool weight increased by 22% (95% CI, 5-39),
water content by 20% (2-38%) and dry weight by 24% (4-43%) 6.

3.

Studies Examining Adherence to low-FODMAP diets
Dietary adherence is crucial to the success of a low-FODMAP diet, however

most people do not find the diet easy to incorporate into their life 8,10. That being said,
studies have shown high adherence rates among functional gastrointestinal disorder
(FGID) subjects both when all foods are provided in the form of test drinks (>95%) 11
and when asked to follow dietary advice (75.6%)8. Adherence among the healthy
population who do not experience comparable symptoms has yet to be studied.
Croagh et al. 9 considered change in FODMAP intake, which was used to define
adherence in a study examining administration of a low-FODMAP diet. The study was a
small, combination retrospective/prospective study, with a total of 15 subjects. In the
prospective group, adherence was measured on five subjects using seven-day food
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records reflecting the intake on the final week of the six week intervention. Adherence
was based on total number of “problematic serves” per day, defined as any food that
contained >.5 g of free fructose or fructans, >4 g lactose or any sorbitol, which was based
on guidelines from a previous study25. Each of the five participants reduced the number
of problematic serves per day by at least 6.5 serves (P1=8-1.5, P2=12-2, P3=11-0, P4=90, P5=12-5) by the end of the intervention. According to Croagh et al.9, those with a high
baseline intake of dietary FODMAPs and good adherence to the diet responded, while
those with a low baseline intake and partial adherence did not 9.
In another study, de Roest et al.8 measured correlations between adherence and
symptoms among IBS patients, finding a positive correlation between adherence to a
low-FODMAP diet and symptom improvement. Follow up questionnaires were used to
measure both adherence and symptoms at a mean follow up time of 15.7 months. All
symptom improvement, including abdominal pain, bloating, flatulence and diarrhea was
significantly associated with adherence (r>0.27, p<0.011). In this 90 subject study, 75.6%
(n=68) of IBS patients adhered to the diet regimen. Breaking down adherence into
subcategories, 45.6% (n=32) followed the diet as taught at all times except on some
occasions; 12.2% (n=11) followed the diet at all times; 13.3% (n=12) patients followed
the diet all the time except eating away from home; 14.4% (n=13) considered themselves
adherent at least 50% of the time; 24.4% (n=22) followed the diet up to 3 months, but not
anymore; 5.6% (n=5) followed the diet as taught immediately, but less than 50% of the
time at the end of the follow-up questionnaire; 4.4% (=4) never followed the diet 8.

3.2 Factors that may contribute to adherence
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Gearry et al. 10 conducted a pilot study that explored factors that may contribute
to non-adherence to a low-FODMAP diet in patients with Inflammatory Bowel Disease
(IBD) based on findings from a previous FODMAP study11. Dietary advice consisted of a
single one-on-one or group counseling session with a dietitian as well as FODMAP
literature and food lists. Adherence was measured using questionnaires via structured
telephone interviews regarding FODMAPs consumption as well as specific questions
concerning FODMAP-containing foods in order to validate the patient’s responses.
According to Gearry et al.10 70% of IBD patients who suffered from FGID were adherent
to advice to follow a low-FODMAP diet. Upon completion of the study, the 72
participants were asked to rate their opinion of the diet on a scale of 0-10 (0=easy,
10=impossible) and obtained median score. Low scores were obtained for the questions
1] how easy was it to implement the diet (median response 3; SD 2.9, range 0-10,
interquartile range 0-5), 2] and how easy was it to buy the appropriate foods (median
responds 3; SD 2.9, range 0-10, interquartile range 1-4) and 3] how would you rank the
overall taste of the diet (median responds 2; SD 2.2, range 0-10 interquartile range 1-4)10.
In addition, 44/72 (61%) said that the foods were not available at their usual shops, the
higher cost of the diet was thought to be problematic for 46/72 (64%) and the median
estimated increase in the cost of food while on the diet was 10% (SD 19, range -10110%, interquartile range 1-25%).
The de Roest et al. 8 study (described above) examined similar factors
contributing to non-adherence in a study consisting of 90 IBS patients. Using
questionnaires, the study found that that fifty-one (60%) patients stated the diet was easy
to follow, 56 (65.1%) could easily find suitable products and 37 (54.7%) were able to
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incorporate the diet easily into their lives; the overall taste was liked by 47 (54.7%)
patients, 21 (24.4%) of patients thought the diet was too expensive8. Last, regarding
dietary advice, sixteen (44.6%) patients believed that simply being given a list of foods to
avoid would have been as effective as seeing a dietitian while 37 (44.6%) of patients
would have liked to have seen the dietitian for a further follow-up appointment 8.
Additionally, patients were asked to rank order 5 variables reflecting how they
contributed to efficacy/adherence to the diet. Written information (mean rank 1.73
(±0.76)) and dietitian consultation (1.89 (±1.09)) were ranked highest while the support
of family and friends (3.33 (±1.15)), low FODMAP cookbooks (3.89(±1.00) and online
information (4.11 (±1.00)) were ranked as less important. Factors contributing to nonadherence have been investigated in both IBS and IBD populations, but not in healthy
adults.

4.

Potential Limitations of a low-FODMAP diet
Several limitations of a low-FODMAP diet pertaining to dietary quality and

health benefits have been suggested. Malabsorbed FODMAPs provide multiple benefits
including a natural laxative effect due to their osmotic effects6, a prebiotic effect with
beneficial fermentation by-products 12 and production of a low glycemic response
compared to other CHO 21. Some beneficial by-products of fermentation include short
chain fatty acids (SCFA), which may protect against colon cancer as well as promote
satiety 89, and synthesis of B vitamins and vitamin K 90.

4.2 FODMAPs: Low-glycemic index nutrients
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FODMAPs are nutrients with lower glycemic indexes 37,38. Low glycemic index
foods are proven beneficial in the treatment and prevention of metabolic syndrome,
diabetes and CVD 39-42. Although the mechanisms underlying the effects of these foods
are not completely understood it is hypothesized that low-GI diets maintain better
regulation of blood glucose, which decreases oxidative stress and lowers inflammation 42.
In addition to immediate response, consumption of low glycemic foods reduces glycemic
response at subsequent meals up to 4 hours later 21.
Nilsson et al.42 conducted a study examining the effect of evening consumption
of indigestible and low glycemic-index foods (50 grams) on a subsequent breakfast. The
study included healthy subjects exclusively and used breath hydrogen testing to reflect
colonic fermentation. Testing was done prior to and after a subsequent standardized
breakfast as well as three hours postprandial. Results were healthy subjects improved
glucose tolerance, lowered inflammatory markers and increased satiety (which
contributes to weight control and obesity prevention) suggesting multiple benefits of
including indigestible and low-GI foods. Upon further investigation, glucose response
was inversely correlated with colonic fermentation (r=-0.25; p<0.05) and breath
hydrogen was positively correlated to satiety (r=0.27; p<0.01). Nilsson et al. concluded
that the effects could be attributed to mechanisms involving the prebiotic effect of poorly
digested CHO.

4.3 FODMAPs: Prebiotic Actions
Prebiotics are any nondigestible substances that encourage the growth and
activity of favorable intestinal bacteria, known as probiotics, therefore improving the host
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health 91 and include the FODMAPs FOS, GOS and inulins 92. Studies have shown that
supplementing with FOS, GOS and inulin encourages growth of the beneficial bacteria
bifidobacteria, at the expense of less desirable groups of bacteria 93,94. Beneficial
probiotics also include the bacteria lactobacilli; However bifidobacteria are the usual
target since these bacteria are more readily altered and more prevalent in the human colon
95

. Bifiobacteria also exhibit a preference for oligosaccharides 95. Prebiotics may

promote satiety, weight loss and prevent obesity, lower some risk factors for
cardiovascular disease, enhance the bioavailability and uptake of minerals including
calcium, magnesium and possibly iron, exert protective effects that may prevent colon
cancer, reduce inflammation and symptoms of inflammatory bowel disease and reduce
the prevalence and duration of infectious and antibiotic-associated diarrhea95. Recent
studies have shown that prebiotics can have positive effects on insulin and immune
response and decrease total cholesterol and total glucose concentration after just six
weeks of use 94 and increase the amount of bifidobacteria after just four weeks 96,
however no longer term studies have been reported.
Not all dietary fibers are prebiotics, but all prebiotics such as oligosaccrides are
dietary fibers 97. Benefits of consuming adequate fiber include weight management,
lowering of blood cholesterol, colon cancer risk reduction, prevention and control of
diabetes and enhancement of colonic health 35. Fiber provides the structure of plants and
are thus found in plant-derived foods including vegetables, fruits, whole grains and
legumes35. A low-FODMAP diet restricts these foods suggesting that dietary fiber intake
might be reduced. No study has measured change in fiber intake in diets that vary in
FODMAP content.
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4.4 Dietary quality of Low-FODMAP diets
Only one retrospective study has calculated the diet of free-living subjects who
received low-FODMAP dietary advice. Not one study has looked exclusively at healthy
adults, changes in intake or looked at overall diet quality as compared to established
guidelines. Ostgaard et al.23 examined the breakdown of IBS patients diets who received
low-FODMAP dietary education (guided n=43) two years prior. The study compared
those results to IBS patients who did not get FODMAP education (unguided n=36) and to
a group of healthy individuals (control n=35). Food frequency questionnaires (FFQ) were
used to assess dietary intake. Dietary advice consisted of two sessions with a trained
nurse for one hour each. The FFQ found there was no statistical difference in the intake
of calories, CHO, protein, fat or sugar between the guided, unguided and control and a
significantly lower consumption of alcohol (beer and wine) in both the guided and
unguided IBS patients when compared to the control. (Beer and wine: control;45.0±10.9
and 34.2±.9 ml, guided; 21.0±6.5 and 16±2.9 ml, unguided; 13.9±5.9 and 14.5 ±4.3 ml
respectively) 23. Fiber however was not assessed as significantly different among the
three groups and overall dietary quality was not measured.

5.

CHO malabsorption ‘s effect on mood
Multiple studies have been conducted linking specific CHO malabsorption to

changes in mood or increases in undesirable mood states. Ledochowski et al. conducted a
series of studies in otherwise healthy adults linking fructose malabsorption 98 and lactose
malabsorption 99 to early signs of depression and mood disturbances, and fructose and
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sorbitol reduced diets 100 to increases in mood among malabsorbers. Mood was defined
by the participants’ score on the Beck’s Depression Inventory-Questionnaire (BDI) 101.
When examining the connection between malabsorption and mood scores,
Ledochowski et al. considered plasma tryptophan 98. This particular study enrolled fifty
adults with gastrointestinal discomfort but without any clinical diagnosis. Subjects were
tested for fructose malabsorption using breath hydrogen testing. Baseline testing was
done followed by administration of 50 grams of fructose. Breath hydrogen testing was
then repeated every 30 minutes for the next two hours. Fructose malabsorption was
defined as an increase of more than 20 ppm over basal fasting value. Patients (n=35)
(70%) were classified as fructose malabsorpers. Fructose malabsorbers and nonmalabsorbers then had their plasma trophophan measured and completed the BDI. A nonsignificant trend to higher BDI scores was seen comparing fructose malabsorbers to nonmalabsorbers (9.47±7.35 vs. 7.07 ± 4.62, p=NS). However once divided based on gender,
BDI was higher for female fructose malabsorbers (12.30±7.16) than female nonmalabsorbers (6.66 ±5.50, p=.002). No difference was seen in males. Mean plasma
typtophan was significantly lower in fructose malabsorbers than non-malabsorbers
(p=.02) and once again, divided by gender, lower tryptophan concentrations were only
seen in females (fructose malabsorbers: 61.3±14.0μM, normal:74.7±16.5 μM, p=.03).
Upon further statistical analysis, individuals with tryptophan concentrations lower than
the median (=67.0μM) more often presented with a BDI score above the median (p=.036;
Fisher exact test) and when analyses was restricted to fructose malabsorbers, a significant
inverse relationship between tryptophan concentration and BDI scores were found both
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overall (n=35; r=-0.348, p=.043) and when restricted to females (n=24; rs=-0.503,
p=.014).
5.2 Tryptophan levels and Mood
Although serotonin (5-HT) is often thought of as a neurotransmitter exclusive to
the central nervous system (CNS) due to its well-defined role in expression of depression,
arousal, pain and other characteristics commonly attributed to CNS functioning, the
major source of bioavailability is located in the bowel 102. Low levels of brain 5-HT can
contribute to decreases in mood 103 and are therefore the target of several antidepressants.
The precursor of 5-HT is tryptophan, which is considered an essential amino acid,
indicating it cannot be produced internally and must be obtained externally via the diet.
Lowering tryptophan levels through dietary modifications is associated with a
postprandial mood-lowering effect 104.
Ledochowski et al.98 demonstrated that malabsorption of an individual
FODMAP has been associated with decreases in tryptophan levels. According to this
study, high intestinal fructose concentrations, as is the case with fructose malabsoprtion,
seem to interfere with L-tryptophan metabolism and thus reduce the bioavailability of 5HT. It was then hypothesized that this could be due in part to a combination of increased
transit time and the phenomenon known as the Maillard reaction. The Maillard reaction,
which is primarily associated with food science, is a heat-driven process where an amino
acid becomes bound to a simple sugar. Ledochowski et al. theorized that malabsorbed
fructose results in a fructose-L-tryptophan complex, which is then lost in excretion.
Based on this theory, a diet high in multiple, poorly absorbed CHOs such as a high50

FODMAP diet, may lead to reduced levels of the bioavailability of tryptophan and
possibly impact mood perception however, proof of concept studies are needed.
6.

Conclusion
Irritable Bowel Syndrome (IBS) is the most commonly diagnosed

Gastrointestinal (GI) condition in the United States 48. In 2012, it was estimated that 10%
of Americans meet the diagnosable criteria for IBS, translating to 30 million people 48.
IBS is an umbrella term that incorporates a spectrum of chronic or recurrent symptoms
including abdominal pain, bloating, distension, excessive wind and altered bowel habits
when anatomical abnormalities and inflammation have been excluded 12. A lowFODMAP diet is now considered an effective strategy for managing symptoms of IBS in
Australia, with interest expanding across the world 12. FODMAPs’ ability to increase GI
symptoms are centered around FODMAPs’ three common functional properties; They are
1) poorly absorbed in the proximal small intestine, allowing substrate to reach the distal
small intestine and proximal colon 2) small and osmotically-active, which increases the
liquidity of luminal content due to osmosis and 3) rapidly fermented by gut microbiota,
increasing the amount of gas present in the colon. Dietary adherence is crucial to the
success of a low-FODMAP diet, however most people do not find the diet easy to
incorporate into their life 8,10. Several limitations of a low-FODMAP diet pertaining to
dietary quality and health benefits have been suggested. Malabsorbed FODMAPs provide
multiple benefits including a natural laxative effect due to their osmotic effects, a
prebiotic effect with beneficial fermentation by-products 12 and production of a low
glycemic response compared to other CHO 21. Additionally malabsorption of certain
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FODMAPs has been linked to increases in undesirable mood states 98-100. Not one study
has looked exclusively at healthy adults, changes in intake or looked at overall diet
quality as compared to established guidelines. A study is needed looking at dietary
quality of low- vs. high-FODMAP diets and should consider adherence and other factors
that may influence efficacy and potential impact of the diet.
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Appendix B
Methods

Study Design
The study was done by the Energy Balance Lab (EBL) at The University of
Rhode Island (URI) in the spring/summer 2013. It was a randomized, single-blinded,
cross-over study comparing two dietary conditions in a free-living setting; a lowFODMAP and a high-FODMAP diet. In order to ensure that the diet was single-blinded,
the study was entitled “The Carb Study” and the two conditions were labeled “Diet 1”
and “Diet 2” representing the low-FODMAP and high-FODMAP diets respectfully. The
diet instruction booklet that corresponded to each dietary condition was developed
specifically for this project based on multiple published articles 1,5,23,24. The selection
process was randomized, with a coin flip determining which group the first participant
would begin. Each of the two conditions lasted 3 days: Tuesday, Wednesday, and
Thursday. An eleven day wash out period where subjects consumed their normal diet
separated the two conditions. The subjects had baseline measurements and measurements
after completing each diet measured on Tuesday and Friday mornings after a 10 hour
fast. In total, there were five visits: an initial assessment (visit 1), two baseline testing
(visit 2 & 4), two post-diet testing (visits 3 & 5).

Recruitment
The majority of the subjects were recruited from a list of “Potential Study
Volunteers” comprised of adults who were candidates or participants in previous,
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nutrition-related studies and expressed a desire to be contacted for future studies. A mass
email was sent from the EBL team to any adult on this list. In addition to this list,
classroom announcements were made in three nutrition classes made up of primarily
nutrition students or students in other health-related fields. The estimated attrition rate
was expected to be low and was based on a study done by Dr. Melanson (The PI) with a
similar demographic and study design (25). In total, 20 participants began the
intervention, the attrition rate was 20% and the final sample size was 16. Of the four who
did not complete, one subject dropped out due to a hospitalization that involved antibiotic
treatment and three subjects did not report to the lab for an appointment.

Subjects
Overall, 18 healthy subjects, free of any gastrointestinal illness completed the
study. Gastrointestinal illness included celiac disease, IBS, lactose or gluten intolerance,
diverticular disease, colitis such as Crohn’s disease or ulcerative colitis or stomach ulcers.
Additional exclusion criteria included any food allergies, being a current smoker, being
on a weight loss diet, pregnant or lactating, type 1 or 2 diabetes, adrenal disease, kidney
or bladder problems a thyroid disease or currently taking any appetite suppressant
medications.

Initial Assessment/Screening
During visit 1, potential participants completed an initial assessment and a
screening which assured their status as a healthy adult clear of any GI complications.
Once subjects were declared eligible, demographic measurements and assessment of
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body fat percentage using the BOD POD Body Composition System (Life Measurement
Instruments, Concord, Calif., USA) was performed. BODPODs are used to estimate %
fat via air displacement plethysmography (ADP). The procedure has been described in
full in a previous study105. In brief subjects are weighed in minimal clothing. They are
then placed in the BOD POD where measurements of body volume are made. Once
multiple measurements are made, if the body volume is within 150 ml, the BOD POD
then measures thoracic lung volume. From the body mass, body volume and thoracic
lung volume obtained, the BOD POD can then determine body density and % fat.

Baseline testing: Fasting
During the baseline visits, subjects reported to the EBL following a 10 hour fast
where they completed baseline measurements of height, weight, waist circumference, and
an appetite/discomfort questionnaire. In a fasting state, breath hydrogen, capillary
glucose and lipid profile was also collected. (Protocol regarding breath hydrogen,
capillary glucose, lipid profile and changes in appetite are discussed in Appendix C
however it is important to note that change in these variables are being analyzed as part
of another student’s thesis.)The appetite/discomfort questionnaire was a 10 cm visual
analogue scale (VAS) for subjects tor rate hunger, satiety, desire to eat and thirst. The use
of VAS scales is considered a reliable and valid measurement of appetite 106. The
appetite/discomfort scale used is a five question, VAS-format scale that considered
hunger, satiety, thirst and abdominal discomfort.

Baseline testing: Test Meal
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Following these baseline measurements, subjects consumed a high-FODMAP
test meal consisting of: two slices of whole wheat toast, one with 1 tbsp of honey and one
with 1 tbsp of sugar free, no sugar alternative jam, 12 oz of 2% milk and 40 grams of
raisins. The Test meal contained 1.141 grams of polyols, 28.494 grams of fructose, .661
grams of galactose and 18.234 grams of lactose, totaling 47.86 grams of FODMAPs. The
amount of FODMAP was determined using the 2012 version of the Nutrition Data
System for Research (NDS-R) from the Nutrition Coordinating Center (NCC) at the
University of Minnesota. The test meal was comprised to have approximately 50 grams
of FODMAPs. It is of note that NDSR, like most nutrition databases, does not quantify
oligosacchardies such as FOS and GOS, thus, the grams of total FODMAPs is most likely
slightly higher due to FOS commonly found in wheat. This number was based on
standards used in breath hydrogen testing of lactose intolerance 99 and fructose
intolerance 98.

Baseline testing: Postprandial testing
Thirty minutes postprandial, subjects completed the same appetite/discomfort
and repeated the same collection methods as fasting measurements described above. A
third and final round of testing using the same procedures was conducted 60 minutes
postprandial. The break between these three testing points was allocated to subjects
receiving dietary instructions for their intervention, and completion of a 24-hour recall.
The total time of these visits was approximately 75 minutes.

Baseline Testing: Diet Instructions and Diet Booklet
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During baseline visits, subjects met with a member of the research team
educated in the FODMAP diet who provided each subject with a16 page diet instruction
booklet labeled either “Diet 1” or “Diet 2”. The booklets contained detailed lists of
recommended and restricted foods. A brief, 15 minute diet explanation was also provided
which included identifying encouraged and discouraged foods, brief tips and reiteration
of the impotence of adhering to the diet for the purpose of the study’s success. “Diet 1”
corresponded to the low-FODMAP diet and “Diet 2” was the high-FODMAP diet.

Post-Diet Testing
An almost exact replica of baseline testing protocol was used for post-diet
testing. The only addition was the addition of an “opinion regarding the diet” 6 question
mixed VAS and free response questionnaire (Appendix D). The only exemption was that
no dietary instructions were provided during the POST-Intervention. At the end of the
POST-diet visit, subjects were told to either follow their normal diet (visit 3) or were
informed that the study was completed (visit 5). The subjects received a $20 incentive on
visit 3 and a $60 incentive on visit 5.

Post-diet testing: Diet opinion
The diet opinion scale (Appendix D) used during the POST-Intervention was
developed for this project and had not been used in a previous study. The questionnaire
was developed based on a questionnaire created by Gearry et al.10 using items identified
by Shepherd et al.11 as potential barriers to adhering to a low-FODMAP diet. Of note,
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since the completion of this study, a questionnaire with similar items has also been used
by De Roest et al.8.

Additional Questionnaires
In addition to in-lab data collected, subjects were given three days worth of
questionnaires assessing appetite, symptoms and mood. The appetite questionnaire used
was the same questionnaire described earlier, however the abdominal discomfort scale
was omitted. It was filled out pre- and post-meals, mid-afternoon, mid-evening and
before bed, for a total of nine times throughout the day. The mood and the symptom
questionnaires were filled out daily, before bed. The mood questionnaire used (Appendix
D) was a non-validated VAS questionnaire developed by the EBL and used in only one
previous study 31. The format was an eight question, VAS scale. The Symptoms
questionnaire (Appendix D) was a new, 3-item, mixed VAS, yes/no and free response
questionnaire developed by a gastroenterologist at Rhode Island Hospital that had not
been used before in a study.

Instruments and methods for answering research questions
Dietary Quality
During visits 2, 3, 4 and 5, trained researchers conducted a 24 hour food recall
corresponding to all food and beverage items consumed the previous day. The 24-hour
food recall consisted of participants recalling every food or beverage item that they ate on
the previous day, from midnight to midnight. Nutrition calculations were performed
using the Nutrition System for Research (NDS-R) software version 12 developed by the
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Nutrition Coordinating Center, University of Minnestoa, Minneapolis. NDS-R utilizes a
multiple pass method described in full elsewhere 26. Briefly, pass one included obtaining
a quick list of foods consumed in the past 24 hours. In pass two, participants are asked to
produce details regarding foods on their quick list including portion sizes and amounts
eaten. In pass three the list is recited and participants are asked if any information was
forgotten.
Foods that were not in the NDS-R database were cited as “missing foods” and
corrected after the interview was completed. Resolution of a missing food usually
required finding an NDSR substitute (very similar food or a generic version of a food) in
the database and matching that substitute for CHO, protein, fat and kcals. Matching was
defined as within 1-3 grams for each macronutrient and within 10 kcals for energy. For
some foods, the FODMAP content was considered too variable for a substitution (for
example ice cream brands and gluten free products). These foods were emailed to NDSR,
who then provided an accurate nutrient breakdown for those items.

Dietary Quality: Healthy Eating Index 2010
From this NDSR output file, a single dietary quality score entitled The Healthy Eating
Index 2010 (HEI-2010) was obtained through calculations described in greater detail in
Appendix E. The HEI is a measure of dietary quality determined by how well an
individual’s diet compares with federal dietary guidelines, and based directly on the
Dietary Guidelines for Americans (DGA) 29. The DGA are issued every 5 years by the
United States Department of Agriculture (USDA) and the US Department of Health and
Human Services 29. The HEI-2010 is the most up-to-date version, modified from the HEI-
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2005 and based on the release of the 2010 DGA and revised USDA Food Patterns 29. The
actual score computed was a single number ranging from 0-100 with higher numbers
representing better rated diets. The categories considered included total fruit, whole fruit,
total vegetables, greens and beans, whole grains, dairy, total protein foods, seafood and
plant proteins, fatty acids, refined grains, sodium, and empty calories 29. The change in
HEI-2010 score from PRE-, to POST-Intervention was used to define change in dietary
quality score.

Dietary Adherence
NDS-R output files were used to sum total intake (g) of fructose, lactose and the sugar
alcohols (erythritol, inositol, isomalt, lactitol, maltitol, mannitol, pinitol, sorbitol and
xylitol.) These items were used to define FODMAP intake. It is important to note that
because NDS-R (as well as most other nutrition database systems) cannot calculate
consumption of GOS or FOS, this number obtained does not translate to total FODMAP
intake. Dietary adherence therefore, was defined according to available FODMAP items.
Adherence to the low-FODMAP diet was defined as a reduction of FODMAP from
baseline to day three of each diet. Adherence to the high-FODMAP diet was defined as
an increase in FODMAP from baseline to day three of the diet. There are currently no set
values to define high or low-FODMAP diets

Comparing Mood with FODMAP Intake, Symptoms and Breath Hydrogen
As mentioned previously, mood and symptom questionnaires were obtained for
each day of the 3 day intervention. Participants completed these questionnaires at night,
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just prior to bed. The scores of interest were the scores obtained on the third day of the
intervention. FODMAP intake for that same day was reflected on the 24 hour food recall
obtained during the Post-Diet testing. This allowed for comparison of participants’ mood
scores to 1) their intake of FODMAP, 2) their reported symptoms 3) their HEI-2010
scores on the same day and at the end of the three day intervention. Appendix F show
questionnaire data from mod variables that did not make it into the manuscript results.

Statistics
This was a secondary data analysis from a larger study powered on blood glucose.
Statistical analyses were performed using SPSS (v22). All variables met criteria for
normality. Baseline comparisons between subjects assigned to the two orders were
conducted using t-tests and Χ2 tests. Primary outcomes (grams FODMAP and HEI-2010
scores) were assessed using separate 2 (treatment) x 2 (time) x 2 (order) mixed factorial
ANOVA followed by within-treatment paired t-tests (baseline and intervention). Eta2 was
calculated to estimate effect size using Cohen’s categories of small (.1), medium (.6) and
large (.14)32. Energy intake (kcal/day) was assessed using similar analyses. All other
inferential analyses of dietary components were performed using a 2 x2 repeated
measures ANOVA where the independent variables were treatment (low- vs. highFODMAP) and time (baseline vs. intervention). Paired t-tests compared mood, symptoms
and compliance factors between treatments and Pearsons bivariate correlations explored
relationships between variables. P value <0.05 was considered statistically significant.

Required Resources
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Department computers with NDSR and SPSS were already set up and working in the
EBL. All necessary laboratory equipment including the Alere Cholestech LDX System
and the Quintron Model CM Clinical Microlazer were already set up and working in the
EBL. Food models were already available in the EBL
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Appendix C: Protocol for breath hydrogen, blood glucose and blood lipid collection
Breath Hydrogen Collection Protocol
Warm Up Period
1.
Turn on system 15 minutes (at least) prior to use.
2.
Following the warm up period, adjust the front panel labeled “parts per million”
until it reads “000”
Calibration
Materials needed- Reference gas, SivRite cartridge, syringe, stopcock
1.
Pull “out” valve stem so that pilot light turns GREEN
2.
Using a syringe with stopcock, extract 20 ml of reference gas (concentration of
98 ppm).
3.
Place the SivRite cartridge directly into the flush port.
4.
Inject the reference gas into the machine via the SivRite cartridge. (if reference
gas cannot be injected, check to make sure A-the valve stem is pulled all the way out and
B- the stopcock is open.)
5.
After the gas has been flushed, push the valve stem “in” until the GREEN light
changes to RED and observe the meter response.
6.
Once the meter response becomes stable, adjust the “calibrate” knob until it
reads “098”.
7.
Pull the valve stem “out” and the meter response should read “000”.
8.
If meter response does not read “000”, re-zero the instrument and repeat
calibration process.
9.
Continue process until instrument is properly calibrated
Collection of Sample:
Materials needed- Breath Collection kit (including mouth piece, collection
bag and discard bag), SivRite cartridge, syringe, stopcock
1.
Ask subject to take deep breath and hold breath for 15 seconds.
2.
After 15 second has passed, have subject exhale normally into collection bag.
3.
Label Sample bag (Subject ID and Pre or Post meal).
Analyzing a Sample
1.
Using a syringe with stopcock, extract 20 ml of the sample gas from the
collection bag.
2.
Pull the valve stem “out” so that the pilot light turns GREEN
3.
Connect the SivRite Cartridge to the flush port.
4.
Inject 20 ml of the sample gas into the machine via the SivRite Cartridge
5.
Push valve stem “in” until the light turns RED
6.
Record the H2 concentration (ppm) presented in the meter response
7.
Pull Valve stem “out” so that light turns GREEN and release the sample from
the port
8.
Using the syringe, back flush 40 ml of room air into the machine.
9.
Repeat analysis using an additional 20 ml taken from the original collection bag.
10.
Take the average of the two numbers
This process can be done after the participant has left. Samples are good for 2-3
hours in the breath collection bag
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Appendix D: Questionnaires
Opinion regarding the diet questionnaire
SUBJECT #: ________

DATE: _________________

DIET: 1

2

These questions relate to your personal opinion regarding the diet you had been asked to
follow. Please rate yourself by placing a small “x” across the horizontal line at the point
which best reflects your present feelings.
1.

How easy/difficult had it been to implement the diet?

very easy
2.

very difficult

How easy/difficult had it been to adhere to the diet?

very easy
3.

very difficult

How easy/difficult was it to obtain the appropriate food?

very easy
4.

very difficult

How would you rank the overall taste?

did not like it at all

liked it very much
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5.

What were the biggest challenges in following this diet?

6.

What did you like about this diet?
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The Mood Questionnaire
SUBJECT:.#: ________

DATE: _________________

DIET: 1

2

*Please fill this once a day before bed
These questions relate to your “mood state” at this time. Please rate yourself by placing a
small “x” across the horizontal line at the point which best reflects your present feelings.
1.

How alert do you feel?

very little
2.

very much

How sad do you feel?

very little
3.

very much

How tense do you feel?

very little
4.

very much

How much of an effort is it to do anything?

very little

very much
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5. How happy do you feel?

very little

very much

very little

very much

6. How weary do you feel?

7. How calm do you feel?

very little

very much

very little

very much

8. How sleepy do you feel?
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The symptom questionnaire
Abdominal Symptoms Questionnaire
Please fill out this form every evening (preferably prior to going to bed) for each of the 3
days prior to your next scheduled visit.
1.

A) Are you currently suffering from any abdominal pain?

Yes

No

B) If yes, how severe is the abdominal pain?

No pain

Severe Pain

C) Please enter the number of days that you get the pain in every 10 days?
*For example, if you enter 4 it means that you get pain 4 out of every 10
days. If
you get pain every day, enter 10.
Number of Days with pain:

2.

A) Do you currently suffer from abdominal distension*?
(Bloating, swollen or tight tummy)
(*Women, please ignore distension related to periods)

Yes

No

B) If yes, how severe is you abdominal distension/tightness?

No distension
3.

Very Severe

How satisfied are you with your Bowel Habit?

Un-happy

Very Happy

68

Appendix E: Calculating the Healthy Eating Index 2010 (HEI-2010)
Calculation for the HEI-2010 was based off of a protocol developed by the Nutrition
Coordinating Center (NCC) at the University of Minnesota based off of methods
described in a previous study_ENREF_10630. It is important to note that it is only
possible to estimate an approximation of the HEI-2010 score using NDSR.
Steps:
Step one of calculating the total HEI-2010, involved calculating each of the individual
index components. Step two included taking that number and conforming it to the unit of
measure used in the index (such as servings converted to cups). Step three involved
comparing intake of each item to the score rubric (table 1). Step 4 involves summing the
individual scores to produce a single HEI-2010 score. Two decimal points were used for
every spot.
Table 4: Healthy Eating Index-2010 components and standards for scoring
Component
Optimum
Standard for maximum
Standard for
Score
score
minimum score of
zero
Total Fruita
5
≥0.8 cup eq/1,000 kcal
No fruit
Whole Fruitb
5
≥0.4 cup eq/1,000 kcal
No whole fruit
Total Vegetablesc
5
≥1.1 cup eq/1,000 kcal
No vegetables
Greens and Beansc
5
≥0.2 cup eq/1,000 kcal
No dark-green
vegetables or beans or
peas
Whole Grains
10
≥1.5 oz eq/1,000 kcal
No whole grains
Dairyd
10
≥1.3 cup eq/1,000 kcal
No dairy
Total Protein Foodse
5
≥2.5 oz eq/1,000 kcal
No protein foods
Seafood and Plant
5
≥0.8 oz eq/1,000 kcal
No seafood or plant
Proteinsef
proteins
Fatty Acidsg
10
(PUFAs+MUFAs)/SFAs >2.5 (PUFAs+MUFAs)/SF
As ≤1.2
Refined Grains
10
≤1.8 oz eq/1,000 kcal
≥4.3 oz eq/1,000 kcal
Sodium
10
≤1.1 gram/1,000 kcal
≥2.0 grams/1,000 kcal
Empty Caloriesh
20
≤19% of energy
≥50% of energy
a Includes

100% fruit juice.
all forms except fruit juice.
c Includes any beans and peas not counted as Total Protein Foods.
d Includes all milk products, such as fluid milk, yogurt, cheese, and fortified soy
beverages.
e Beans and peas are included here (and not with vegetables) when the Total
Protein Foods standard is otherwise not met.
b Includes
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f Includes

seafood, nuts, seeds, soy products (other than beverages) as well as
beans and peas counted as Total Protein Foods.
g Includes seafood, nuts, seeds, soy products (other than beverages) as well as
beans and peas counted as Total Protein Foods.
h Calories from solid fats, alcohol, and added sugars; threshold for counting
alcohol is >13 g/1000 kcal.

© 2013 Regents of the University of Minnesota. All rights reserved
Calculation based on individual index component:
Total Fruit
1.
The following items were extracted from output file 9 from NDSR and summed
up to give total fruit (servings): Citrus juice, fruit juice excluding citrus juice, citrus fruit,
fruit excluding citrus fruit, avocado and similar, fried fruits and fruit-based savory snacks
2.
Total fruit (serving) was than divided by two to produce total fruit (cups)
3.
Total energy expenditure (taking from NDSR output file 04) was first divided
by 1000.
4.
Then total fruit (cups) was divided by the results of step 3
5.
The result of step 2 was then multiplied by the optimum total fruit score (5) and
divided by the standard for maximum total fruit score (.8) to yield the total fruit score. A
maximum of 5 and minimum of 0 was used
Whole Fruit
1.
The following items were extracted from output file 9 from NDSR and summed
up to give whole fruit (servings): citrus fruit, fruit excluding citrus fruit, avocado and
similar, fried fruits and fruit-based savory snacks
2.
Whole fruit (serving) was than divided by 2 to produce total fruit (cups)
3.
Total energy expenditure (taking from NDSR output file 04) was first divided
by 1000
4.
Whole fruit (cups) was divided by the results of step 3
5.
The result of step 2 was then multiplied by the optimum whole fruit score (5)
and divided by the standard for maximum whole fruit score (.4) to yield the whole fruit
score. A maximum of 5 and minimum of 0 was used
Total Vegetables
1.
The following items were unconditionally extracted from output file 9 from
NDSR and summed up to produce total vegetables (servings): Dark-green vegetables,
deep yellow vegetables, tomato, white potatoes, fried potato, other starchy vegetables,
other vegetables, friend vegetables and vegetable juice.
2.
Legumes (cooked dried beans) was extracted and added to the total vegetable
component score only if the “total protein foods” (including legumes (cooked dried
beans)) max score (>2.5 oz eq/1000 kcals) was reached.
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3.
Total vegetables (serving) was than divided by 2 to produce total vegetables
(cups)
4.
Total energy expenditure (taking from NDSR output file 04) was first divided
by 1000.
5.
Then total vegetables (cups) was divided by the results of step 4
6.
The result of step 3 was then multiplied by the optimum total vegetable score
(5) and divided by the standard for maximum total vegetable score (1.1) to yield the total
vegetable score. A maximum of 5 and minimum of 0 was used
Greens and Beans
1.
Dark green vegetables (servings) from output 09 was extracted and used as the
greens and beans score
2.
Legumes (cooked dried beans) was extracted and added to the total vegetable
component score only if the “total protein foods” (including legumes (cooked dried
beans)) max score (>2.5 oz eq/1000 kcals) was reached.
3.
Greens and beans (serving) was than divided by 2 to produce greens and beans
(cups)
4.
Total energy expenditure (taking from NDSR output file 04) was first divided
by 1000.
5.
Then greens and beans (cups) was divided by the results of step 4
6.
The result of step 3 was then multiplied by the optimum total vegetable score
(5) and divided by the standard for maximum total vegetable score (.2) to yield the total
vegetable score. A maximum of 5 and minimum of 0 was used
Whole Grains
1.
The following items were extracted from output file 09 from NDSR and
summed up to produce whole grains (oz equiv): Grains, flours and dry mixes-whole
grains, loaf-type bread and plain rolls- whole grain, other bread (quick breads, corn
muffin, tortillas)-whole grain, crackers-whole grain, pasta-whole grain, ready-to-eat
cereal (not presweetened)-whole grain, ready-to-eat cereal (presweetened)-whole grain,
cakes, cookies, pies, pastries, donnish, doughnuts and cobblers-whole grain, snack barswhole grain, snack chips-whole grains, popcorn, and flavored popcorn.
2.
Total energy expenditure (taking from NDSR output file 04) was first divided
by 1000.
3.
The result of step 1 was then multiplied by the optimum whole grains score (10)
and divided by the standard for maximum total vegetable score (1.5) to yield the whole
grains score. A maximum of 10 and minimum of 0 was used.
Diary
1.
The following items were extracted unconditionally from output file 9 from
NDSR and summed up to give total fruit (servings): milk-whole, milk, reduced fat, milk,
low fat and fat free, milk, nondiary, ready-to-drink flavored milk, whole, ready-to-drink
flavored milk-reduced fat, ready-to-drink flavored milk-low fat and fat free, sweetened
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flavored milk beverage power with non-fat dry milk, artificially sweetened flavored milk
beverage with non-fat dry milk, cheese-full fat, cheese-reduced fat, cheese-low fat and fat
free, cheese-nondairy, yogurt-sweetened whole milk, yogurt-sweetened low fat, yogurtsweetened fat free, yogurt- artificially sweetened whole milk, yogurt- artificially
sweetened low fat, yogurt-artificially sweetened fat free, yogurt-nondairy, pudding and
other diary deserts, artificially sweetened pudding and other diary deserts, dairy-based
sweetened meal replacement/supplement, diary-based artificially sweetened meal
replacement/supplement
2.
Frozen diary deserts was also obtained from output file 09, then times by three
and added to the score obtained in step one to produce the total diary score
3.
Total energy expenditure (taking from NDSR output file 04) was first divided
by 1000.
4.
Then total diary (cups) was divided by the results of step 3
5.
The result of step 4 was then multiplied by the optimum total diary score (10)
and divided by the standard for maximum total fruit score (1.3 cups) to yield the diary
score. A maximum of 10 and minimum of 0 was used
Total Protein Score
1.
The following items were extracted unconditionally from output file 9 from
NDSR and summed up to total protein (oz equiv): beef, lean beef, veal, lean veal, lamb,
lean lamb, fresh pork, lean fresh pork, cured pork, lean cured pork, game, poultry, lean
poultry, fried chicken-commercial entrée and fast food, fish-fresh and smoked, lean fishfresh and smoked, fried fish-commercial entrée and fast food, shellfish, fried shellfishcommercial entrée and fast food, cold cuts, lean cold cuts and sausage, organ meats, baby
food meat mixtures, eggs, egg substitute, nuts and seeds, nuts and seed butters and meat
alternative.
2.
From the NDSR output file 09, (legumes x2) was added only if the score from
step 1 was less than <2.5 oz/1000 kcals.
3.
Total energy expenditure (taking from NDSR output file 04) was first divided
by 1000.
4.
Then total protein score (oz) was divided by the results of step 3
5.
The result of step 4 was then multiplied by the optimum total diary score (5) and
divided by the standard for maximum total protein score (2.5 oz) to yield the diary score.
A maximum of 5 and minimum of 0 was used
Seafood and plant protein
1.
The following items were extracted unconditionally from output file 9 from
NDSR and summed up to seafood and plant protein (oz equiv): fish-fresh and smoked,
lean fish- fresh and smoked, fried fish-commercial entrée and fast food, shellfish, fried
shellfish- commercial entrée and fast food, nuts and seeds, nut and seed butters, meat
alternative
2.
From the NDSR output file 09, (legumes x2) was added only if the score from
step 1 was less than <2.5 oz/1000 kcals.
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3.
Total energy expenditure (taking from NDSR output file 04) was first divided
by 1000.
4.
Then total protein score (oz) was divided by the results of step 3
5.
The result of step 4 was then multiplied by the optimum total diary score (5) and
divided by the standard for maximum total protein score (.8 oz) to yield the diary score.
A maximum of 5 and minimum of 0 was used
Fatty acids
1.
From NDSR output file 04 the sum of all PUFAs and total MUFAs were
extracted and added together
2.
From NDSR output 04 the sum of all SFAs were added together
3.
The result of step 1 was divided by the result of step 2
4.
The following equation was used to determine the fatty acid component score
(result of step 3-1.2)*10/1.3. A minimum of 0 and a maximum of 10 was used
Refined Grains
1.
The following items were extracted from output file 9 from NDSR and summed
up to give refined grains (oz equiv):grains, flour and dry mixes-some whole grains, grain,
flours and dry mixes-refined grain, loaf-type bread and plain rolls-some whole grain,
loaf-type bread and plain rolls-refined grains, other bread (quick bread, corn muffins,
tortillas)- some whole grain, other breads (quick bread, corn muffins, tortillas)-refined
grain, crackers-some whole grains, crackers-refined grains, pasta-some whole grain,
pasta-refined grains, ready-to-eat cereal (not presweetened)- some whole grains, readyto-eat cereal (not presweetened)-refined grain, ready-to-eat cereal (presweetened)-some
whole grain, ready-to-go cereal (presweetened)-refined grain, cakes cookies, pies,
pastries, danish, doughnuts and cobblers-some whole grain, cakes cookies, pies, pastries,
danish, doughnuts and cobblers-refined grains, Snack bar-Some whole grain, snack barsrefined grains, snack chips-some whole grains, snack chips-refined grains, baby food
grain mixtures-refined grains
2.
Total energy expenditure (taking from NDSR output file 04) was first divided
by 1000.
3.
Then total protein score (oz) was divided by the results of step 3
4.
The following formula was then applied =2.5-((the result of step 3)-1.8).
5.
The following formula was then used to yield the final refined grain score ((the
result of step 5)*10/2.5). A minimum of 0 and maximum of 10 was used.
Sodium
1.
The total amount of sodium (mg) extracted from output 09 from NDSR was
obtained and multiplied by 1000 to yield sodium in g
2.
Total energy expenditure (taking from NDSR output file 04) was first divided
by 1000.
3.
The following formula was then applied =.9-((result of step 2)-1.1)

73

4.
The following formula was then used to yield the final refined grain ((result of
step 3)*10/0.9) a minimum of 0 and a maximum of 10 was used
Empty calories
1.
From NDSR output file 04:
a.
Saturated fat (g) x 9 kcals/gram=kcals from saturated fat
b.
Total trans fat (g) x 9 kcal/gram= kcal from trans fat
c.
Added sugar (by total sugar (g)) x 4 kcal/gram=kcal from added sugar
2.
From NDSR output file 04, alcohol consumption was determined by the
following steps:
a.
Total daily energy intake (kcals) X 0.013 (g/kcal allowable alcohol)= allowable
alcohol (g)
b.
If alcohol (g) is > than allowable alcohol (g), then:
i.
[alcohol (g) – allowable alcohol (g)] x 7 kcal/g = kcal from excess alcohol
3.
Sum the results of 1-a,-b,-c and 2-b-i
4.
Based on the total energy intake from output file 04, the following equation was
used
a.
[kcals from empty calories/total kcals] X 100 = % energy from empty calories
5.
Then, the following equation was used: 100-(result of step 4-a)
6.
The following formula was then used to yield the final empty calorie score:
((the result of step 5-50))*20/31. A minimum of 0 and a minimum of 20 was used
Calculating the total HEI-2010
1.
The results of each individual component scores was added together to yield the
HEI-2010
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Appendix F: Tables & Other Results
Table 5: Differences in mood and GI distress scores between the low and highFODMAP diet (n=16)
LowHighFODMAP
FODMAP
Δ
t
Alert
4.44±2.51
6.03±2.80
-1.58
-1.904
Sad
2.46±2.14
4.14±3.44
0.32
0.740
Tense
4.14±2.57
3.44±2.46
0.71
0.937
Effort Needed
4.73±2.59
4.04±2.52
0.69
1.437
Happy
6.19±1.76
6.55±1.68
-0.36
0.621
Weary
5.86±3.01
3.88±2.61
1.98
2.894*
Calm
5.49±2.38
5.68±2.31
-0.19
-.241
Sleepy
7.00±2.23
6.74±1.98
0.27
.469
Ab. Pain
.61±1.40
.31±.99
0.3
.885
Ab. Distention
.98±1.86
.58±1.86
0.39
.573
Satis. With BM
6.23±1.56
6.36±2.44
-0.08
0.889
*=p<.05
Differences between low- and high-FODMAP diet compared using a Paired ttest

75

Tables 6: The correlation between selected nutrients, mood score and GI score
Alert

Sad

Tense

Effort needed

Happy

Weary

Calm

Sleepy

Abd Pain

Abd Distention

Satis. With BM

.487**

.098

-.284

.005

.274

-.269

.050

-.243

-.186

-.116

.165

HEI-2010

-.204

.276

.297

.211

-.363*

.222

-.151

.314

-.214

.006

-.048

Total Calories (kcal)

.357*

-.036

-.257

-.096

.224

-.081

.193

-.196

-.047

.078

-.054

Total Fat (g)

.427*

-.075

-.400*

-.288

.125

-.306

.138

-.338

-.180

.042

-.095

% Cal from fat

.121

-.066

-.345

-.368*

-.109

-.448

.033

-.254

-.197

-.089

-.170

Total Protein (g)

.226

.203

-.126

.027

-.196

.022

-.189

-.070

-.230

.166

.016

-.113

.345

.176

.155

-.623**

.139

-.531**

.215

-.212

.033

.161

FODMAP intake

% Cal From Protein
Total CHO (g)

.313

-.078

-.201

-.007

.344

.029

.300

-.081

.004

.073

.028

% Cal From CHO

.022

-.107

.145

.221

.393*

.282

.235

.153

.192

.109

.134

Starch (g)

.160

-.100

-.178

.028

.296

.084

.290

.104

.052

.123

-.005

Total Fiber (g)

.189

.064

-.172

.081

.057

.139

.314

.080

-.189

.052

-.022

Total Sugar

-.071

-.156

-.070

.319

-.049

.205

-.257

-.025

-.030

.098

.473**

-.056

-.356*

.106

.376*

.086

.350

-.238

-.116

.048

.270

lactose (g)

.390*

-.020

-.217

-.125

.169

-.437*

-.223

-.067

-.168

-.147

.086

Fructose (g)

.314

.118

-.201

.090

.214

.021

.235

-.253

-.088

-.005

.145

total sugar (g)

.381*

-.071

-.156

-.070

.320

-.048

.203

-.256

-.025

-.030

.098

Added Sugars

.288

-.100

-.122

-.159

.237

-.010

.180

-.323

.020

.041

.033

glycemic Index

.040

-.087

.111

.202

.194

.385*

-.120

-.030

.296

.445*

.095

Caffeine

.252

-.295

-.435*

-.388*

.171

-.142

.333

-.376*

-.200

.244

-.159

Abd. Pain

-.384*

-.032

.352

.234

-.002

.377*

-.142

.193

Abd. Distention

-.093

.051

.065

.019

-.209

.212

.016

.124

Satis. With BM

.008

.022

.030

.459**

.115

.382*

-.084

.286

76

.381*

Glucose (g)

Table 7: Healthy Eating index-2010 raw numbers (unadjusted per 1000 kcal)
Low-FODMAP diet

High-FODMAP diet

ANOVAa

HEI Component

Baseline

Day 3

Δ

Baseline

Day 3

Δ

F (1,15)

η2

Total Fruit (cups)

0.77±1.02

.93±.88

0.17

.93±1.15

.75±.60

-0.18

0.51

-

Whole Fruit (cups)

.62±.78

.79±.83

0.17

.65±.77

.45±.43

-0.19

1.34

-

Total Vegetable (cups)

1.50±1.41

1.75±1.40

0.25

1.65±1.19

1.13±1.07

-0.52

1.82

-

Greens & Beans (cups)

.21±.59

.40±.57

0.19

.45±.75

.29±.47

-0.17

2.22

-

Whole Grain (oz)

2.07±3.55

1.16±1.33

0.9

2.01±3.15

1.94±2.23

-0.07

0.72

-

Dairy (cups)

2.29±1.67

1.11±1.29

-1.18

2.85±3.44

3.16±3.30

0.3

2.01

-

Total Protein (oz)

4.88±4.99

7.08±5.98

2.19

4.80±4.52

6.06±4.93

1.26

0.15

-

Seafood & Plant (oz)

1.20±2.85

1.49±2.14

0.29

1.99±3.12

1.27±2.86

-0.72

0.37

-

Refined Grain (oz)

6.47±4.65

2.79±3.46

-3.67**

5.59±4.62

7.20±4.63

-1.61

10.562**

.41

Empty calories (kcals)

620.02±455.62

342.08±283.96

-277.94*

552.56±445.97

610.49±411.47

57.93

8.02*

.35

*=P<.05, **=P<.01
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A 2 (treatment) X 2 (time) repeated measures ANOVA with post hoc ttest was used.
a

= the time*treatment interaction F statistic reported

Table 8: Correlation between FODMAP intake, mood scores and HEI-2010 scores
Correlation Coefficients (n=15-16)
FODMAP Intake
LowHighFODMAP
FODMAP
Mood variable
Alert

FODMAP Intake
LowHighFODMAP
FODMAP
HEI- 2010 variable

.343

.497

Total Fruit Score

.089

-.241
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Sad

.305

-.014

Whole Fruit Score

-.100

-.205

Tense

-.218

-.285

Total Vegetable Score

.303

.187

Effort needed

.189

-.054

Greens and Beans Score

.070

-.023

Happy

.159

.423

Whole Grain Score

-.171

-.296

Weary

-.068

-.282

Dairy Score

.106

Calm

.310

-.337

Total Protein Score

-.220

.532*
-.328

Sleepy

-.311

-.163

Seafood & Plant Score

.370

-.362

Fatty Acid Score

.296

.490

Refined Grain Score

-.054

-.016

Sodium Score

-.228

-.363

Empty Calorie Score

-.221

-.420

Total HEI-2010

-.023

-.554*

*p<.05

Additional Questionnaire Results: Opinions regarding the diet
After completion of each diet, Random subjects (low-FODMAP n=9, high-FODMAP
n=7) completed a 10 cm VAS scale regarding their opinion of the diet. The median score
for “How easy/difficult had it been to implement the diet? “ (0=very easy, 10=very
difficult) were higher (more difficult) for the low FODMAP diet (median response 6.4,
SD= 2.1, range 0.9-8.0, interquartile range 2.1) compared to the high-FODMAP diet
(median response 4.8, SD=2.8, range 1.1-8.3, interquartile range=3.4). The median score
for the question “How easy/difficult had it been to adhere to the diet?” (0=very easy,
10=very difficult) was higher for the low-FODMAP diet (median responds 5.7, SD= 1.9,
range 1.2-7.8, interquartile range= 1.9) compared to the high-FODMAP diet (median
responds 4.6, SD= 2.4, range 0.8-7.3, interquartile range= 4.7). The median score for the
question “How easy/difficult was it to obtain the appropriate food?” (0=very easy,
10=very difficult) was lower (easier) for the low-FODMAP diet (median responds 2.5,
SD= 1.7, range 1.2-5.8, interquartile range 3.2) compared to the high-FODMAP diet
(median responds 4.5, SD= 2.3, range .9-5.9, interquartile range 4.7). Median scores for
the question “How would you rank the overall taste?” (0=did not like it at all, 10=liked it
very much) were lower for the low-FODMAP diet (median score 4.6, SD= 2.4, range 08.0, interquartile range 2.2) compared to the high-FODMAP diet (median scores 7.0,
SD= 1.5, range 4.7-8.9, interquartile range 2.6).
Two free response questions were also included on the questionnaire. For the
question “What were the biggest challenges in following this diet?” responses for the
low-FODMAP diet included: 1)lack of variety, 2)changing from his/her normal diet
(n=2), 3) food availability, 4)restriction of milk and apples, 6)lack of options in school
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dining hall, 6)unable to use sweeteners and 7)having to pay close attention to foods eaten.
For the question, “What did you like about this diet?” responses from the low-FODMAP
diet included 1)trying different foods (2), 2)increasing fruits (1) and vegetables (2), 3)
realizing how many carbohydrates he/she consumes, 4) enjoyed options (did not specify
if this means as compared to the high-FODMAP diet and 5) enjoyed the high fiber foods
and eliminating old foods. For the high-FODMAP diet, reported challenges include 1)
changing from normal diet, 2) not eating rice, 3) wanting food not offered on the diet. For
“what did you like about this diet?”, responses on the high-FODMAP diet include
1)realizing what I eat, 2)able to eat pasta, 3)easier to follow (than the low-FODMAP
diet).
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Appendix G. Diet Instruction Booklets
Low-FODMAP diet (Diet 1)
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High-FODMAP diet (diet 2)
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